Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
acheiropody | LMBR1* | Lmbr1* | 1 model | Alliance of Genome Resources | |||
achondrogenesis type IA | TRIP11* | Trip11* | 3 models | Alliance of Genome Resources | |||
achondrogenesis type II | COL2A1* | Col2a1* | 1 model | Alliance of Genome Resources | |||
achondroplasia | FGFR3* | Fgfr3* | 9 models | Alliance of Genome Resources | |||
acrocephalosyndactylia | FGFR2* | Fgfr2* | 8 models | Alliance of Genome Resources | |||
acrodysostosis | PRKAR1A* | Prkar1a* | 1 model | Alliance of Genome Resources | |||
acromesomelic dysplasia, Grebe type | GDF5* | Gdf5* | 2 models | Alliance of Genome Resources | |||
acromesomelic dysplasia, Hunter-Thompson type | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
acromesomelic dysplasia, Maroteaux type | NPR2* | Npr2* | 2 models | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 2 | IFT80* | Ift80* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 3 | DYNC2H1* | Dync2h1* | 1 model | Alliance of Genome Resources | |||
autosomal dominant hypophosphatemic rickets | FGF23* | Fgf23* | 2 models | Alliance of Genome Resources | |||
autosomal dominant osteopetrosis 2 | CLCN7* | Clcn7* | 7 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2A | CAPN3* | Capn3* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2B | DYSF* | Dysf* | 5 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2C | SGCG* | Sgcg* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2D | SGCA* | Sgca* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2E | SGCB* | Sgcb* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2F | SGCD* | Sgcd* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2G | TCAP* | Tcap* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2H | TRIM32* | Trim32* | 2 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2I | FKRP* | Fkrp* | 4 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2J | TTN* | Ttn* | 3 models | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2L | ANO5* | Ano5* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2P | DAG1* | Dag1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive limb-girdle muscular dystrophy type 2U | CRPPA* | Crppa* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 1 | TCIRG1* | Tcirg1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 2 | TNFSF11* | Tnfsf11* | 3 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 3 | CA2* | Car2* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 4 | CLCN7* | Clcn7* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 5 | OSTM1* | Ostm1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 6 | PLEKHM1* | Plekhm1* | 2 models | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 8 | SNX10* | Snx10* | 2 models | Alliance of Genome Resources | |||
Becker muscular dystrophy | DMD* | Dmd* | 1 model | Alliance of Genome Resources | |||
Bethlem myopathy | COL6A1* | Col6a1* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1 | IHH* | Ihh* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A1C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type A2 | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brachydactyly type C | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
brittle cornea syndrome 1 | ZNF469* | Zfp469* | 1 model | Alliance of Genome Resources | |||
campomelic dysplasia | SOX9* | Sox9* | 9 models | Alliance of Genome Resources | |||
Carpenter syndrome | MEGF8* | Megf8* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2K | GDAP1* | Gdap1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2O | DYNC1H1* | Dync1h1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2P | LRSAM1* | Lrsam1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Q | DHTKD1* | Dhtkd1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2S | IGHMBP2* | Ighmbp2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease axonal type 2Z | MORC2* | Morc2a*, Morc2b | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease dominant intermediate C | YARS1* | Yars1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease recessive intermediate D | COX6A1* | Cox6a1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1A | PMP22* | Pmp22* | 6 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1B | MPZ* | Mpz* | 10 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1C | LITAF* | Litaf* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 1E | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A1 | KIF1B* | Kif1b* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2A2A | MFN2* | Mfn2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B | RAB7A* | Rab7* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2B1 | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2D | GARS1* | Gars1* | 4 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 2E | NEFL* | Nefl* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | MPZ* | Mpz* | 3 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 3 | PMP22* | Pmp22* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B1 | MTMR2* | Mtmr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B2 | SBF2* | Sbf2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4B3 | SBF1* | Sbf1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4C | SH3TC2* | Sh3tc2* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4D | NDRG1* | Ndrg1* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4E | EGR2* | Egr2* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4H | FGD4* | Fgd4* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 4J | FIG4* | Fig4* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease X-linked dominant 1 | GJB1* | Gjb1* | 4 models | Alliance of Genome Resources | |||
chondrodysplasia with joint dislocations gPAPP type | BPNT2* | Bpnt2* | 1 model | Alliance of Genome Resources | |||
cleidocranial dysplasia | RUNX2* | Runx2* | 4 models | Alliance of Genome Resources | |||
clubfoot | PITX1* | Pitx1* | 1 model | Alliance of Genome Resources | |||
Compton-North congenital myopathy | CNTN1* | Cntn1* | 3 models | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | FREM1* | Frem1* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | PLS3* | Pls3* | 2 models | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | ZFPM2* | Zfpm2* | 1 model | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 1 | AGPAT2* | Agpat2* | 1 model | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 2 | BSCL2* | Bscl2* | 3 models | Alliance of Genome Resources | |||
congenital generalized lipodystrophy type 4 | CAVIN1* | Cavin1* | 1 model | Alliance of Genome Resources | |||
congenital merosin-deficient muscular dystrophy 1A | LAMA2* | Lama2* | 10 models | Alliance of Genome Resources | |||
congenital muscular dystrophy due to integrin alpha-7 deficiency | ITGA7* | Itga7* | 1 model | Alliance of Genome Resources | |||
congenital muscular dystrophy due to LMNA mutation | LMNA* | Lmna* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 10 | DOK7* | Dok7* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 11 | RAPSN* | Rapsn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 12 | GFPT1* | Gfpt1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 19 | COL13A1* | Col13a1* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 3A | CHRND* | Chrnd* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4A | CHRNE* | Chrne* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 4C | CHRNE* | Chrne* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 5 | COLQ* | Colq* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 6 | CHAT* | Chat* | 2 models | Alliance of Genome Resources | |||
congenital myasthenic syndrome 8 | AGRN* | Agrn* | 1 model | Alliance of Genome Resources | |||
congenital myasthenic syndrome 9 | MUSK* | Musk* | 3 models | Alliance of Genome Resources | |||
congenital myopathy 1A | RYR1* | Ryr1* | 3 models | Alliance of Genome Resources | |||
congenital myopathy 1B | RYR1* | Ryr1* | 1 model | Alliance of Genome Resources | |||
craniosynostosis | MSX2* | Msx2* | 3 models | Alliance of Genome Resources | |||
craniotubular dysplasia Ikegawa type | TMEM53* | Tmem53* | 1 model | Alliance of Genome Resources | |||
Crouzon syndrome | FGFR2* | Fgfr2* | 4 models | Alliance of Genome Resources | |||
Desbuquois dysplasia | CANT1* | Cant1* | 2 models | Alliance of Genome Resources | |||
diastrophic dysplasia | SLC26A2* | Slc26a2* | 1 model | Alliance of Genome Resources | |||
Duchenne muscular dystrophy | DMD* | Dmd* | 30 models | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A1* | Col5a1* | 3 models | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | LMNA* | Lmna* | 2 models | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | ACVR1* | Acvr1* | 5 models | Alliance of Genome Resources | |||
fibular hypoplasia and complex brachydactyly | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
Fuhrmann syndrome | WNT7A* | Wnt7a* | 2 models | Alliance of Genome Resources | |||
Fukuyama congenital muscular dystrophy | FKTN* | Fktn* | 6 models | Alliance of Genome Resources | |||
geleophysic dysplasia 1 | ADAMTSL2* | Adamtsl2* | 1 model | Alliance of Genome Resources | |||
gnathodiaphyseal dysplasia | ANO5* | Ano5* | 2 models | Alliance of Genome Resources | |||
Greig cephalopolysyndactyly syndrome | GLI3* | Gli3* | 1 model | Alliance of Genome Resources | |||
Hajdu-Cheney syndrome | NOTCH2* | Notch2* | 4 models | Alliance of Genome Resources | |||
hereditary hypophosphatemic rickets with hypercalciuria | SLC34A1* | Slc34a1* | 2 models | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT1* | Ext1* | 5 models | Alliance of Genome Resources | |||
hypertrichotic osteochondrodysplasia Cantu type | ABCC9* | Abcc9* | 4 models | Alliance of Genome Resources | |||
hypochondroplasia | FGFR3* | Fgfr3* | 1 model | Alliance of Genome Resources | |||
infantile myofibromatosis | PDGFRB* | Pdgfrb* | 1 model | Alliance of Genome Resources | |||
isolated mitochondrial myopathy | CHCHD10* | Chchd10* | 1 model | Alliance of Genome Resources | |||
KBG syndrome | ANKRD11* | Ankrd11* | 2 models | Alliance of Genome Resources | |||
malignant hyperthermia | RYR1* | Ryr1* | 5 models | Alliance of Genome Resources | |||
Marfan syndrome | FBN1* | Fbn1* | 8 models | Alliance of Genome Resources | |||
megaconial type congenital muscular dystrophy | CHKB* | Chkb* | 1 model | Alliance of Genome Resources | |||
microcephalic osteodysplastic primordial dwarfism type II | PCNT* | Pcnt* | 1 model | Alliance of Genome Resources | |||
Muenke Syndrome | FGFR3* | Fgfr3* | 6 models | Alliance of Genome Resources | |||
multiple epiphyseal dysplasia 5 | MATN3* | Matn3* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy | FKRP* | Fkrp* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMT1* | Pomt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B5 | FKRP* | Fkrp* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B6 | LARGE1* | Large1* | 1 model | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | DES* | Des* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 2 | CRYAB* | Cryab* | 4 models | Alliance of Genome Resources | |||
myofibrillar myopathy 5 | FLNC* | Flnc* | 1 model | Alliance of Genome Resources | |||
myostatin-related muscle hypertrophy | MSTN* | Mstn* | 2 models | Alliance of Genome Resources | |||
myotonia congenita | CLCN1* | Clcn1* | 4 models | Alliance of Genome Resources | |||
myotonic dystrophy type 1 | DMPK* | Dmpk* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 10 | LMOD3* | Lmod3* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 11 | MYPN* | Mypn* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 2 | NEB* | Neb* | 4 models | Alliance of Genome Resources | |||
nemaline myopathy 3 | ACTA1* | Acta1* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy 5A | TNNT1* | Tnnt1* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 6 | KBTBD13* | Kbtbd13* | 1 model | Alliance of Genome Resources | |||
nemaline myopathy 8 | KLHL40* | Klhl40* | 1 model | Alliance of Genome Resources | |||
ossification of the posterior longitudinal ligament of spine | ENPP1* | Enpp1* | 2 models | Alliance of Genome Resources | |||
osteoarthritis | GDF5* | Gdf5* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | MATN3* | Matn3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta | COL1A2* | Col1a2* | 5 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 1 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 10 | SERPINH1* | Serpinh1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | COL1A1* | Col1a1* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A1* | Col1a1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | COL1A2* | Col1a2* | 2 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 4 | COL1A1* | Col1a1* | 3 models | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | IFITM5* | Ifitm5* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 6 | SERPINF1* | Serpinf1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 7 | CRTAP* | Crtap* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 8 | P3H1* | P3h1* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 9 | PPIB* | Ppib* | 2 models | Alliance of Genome Resources | |||
osteopathia striata with cranial sclerosis | AMER1* | Amer1* | 2 models | Alliance of Genome Resources | |||
osteoporosis | TNFSF11* | Tnfsf11* | 1 model | Alliance of Genome Resources | |||
osteosarcoma | TP53* | Trp53* | 10 models | Alliance of Genome Resources | |||
otospondylomegaepiphyseal dysplasia, autosomal recessive | COL11A2* | Col11a2* | 1 model | Alliance of Genome Resources | |||
Paget's disease of bone | TNFRSF11A* | Tnfrsf11a* | 1 model | Alliance of Genome Resources | |||
Paget's disease of bone | SQSTM1* | Sqstm1* | 3 models | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR2* | Fgfr2* | 1 model | Alliance of Genome Resources | |||
Pfeiffer syndrome | FGFR1* | Fgfr1* | 2 models | Alliance of Genome Resources | |||
progressive pseudorheumatoid arthropathy of childhood | CCN6* | Ccn6* | 3 models | Alliance of Genome Resources | |||
pseudoachondroplasia | COMP* | Comp* | 2 models | Alliance of Genome Resources | |||
pseudoxanthoma elasticum | ABCC6* | Abcc6* | 2 models | Alliance of Genome Resources | |||
psoriasis | VEGFA* | Vegfa* | 1 model | Alliance of Genome Resources | |||
psoriasis | STAT3* | Stat3* | 1 model | Alliance of Genome Resources | |||
psoriasis 2 | CARD14* | Card14* | 2 models | Alliance of Genome Resources | |||
rheumatoid arthritis | TNF* | Tnf* | 6 models | Alliance of Genome Resources | |||
rickets | CYP27B1* | Cyp27b1* | 2 models | Alliance of Genome Resources | |||
rickets | VDR* | Vdr* | 4 models | Alliance of Genome Resources | |||
rigid spine muscular dystrophy 1 | SELENON* | Selenon* | 1 model | Alliance of Genome Resources | |||
rippling muscle disease 2 | CAV3* | Cav3* | 3 models | Alliance of Genome Resources | |||
Saethre-Chotzen syndrome | TWIST1* | Twist1* | 8 models | Alliance of Genome Resources | |||
Schimke immuno-osseous dysplasia | SMARCAL1* | Smarcal1* | 1 model | Alliance of Genome Resources | |||
Schmid metaphyseal chondrodysplasia | COL10A1* | Col10a1* | 3 models | Alliance of Genome Resources | |||
schneckenbecken dysplasia | SLC35D1* | Slc35d1* | 1 model | Alliance of Genome Resources | |||
sclerosteosis 1 | SOST* | Sost* | 1 model | Alliance of Genome Resources | |||
sclerosteosis 2 | LRP4* | Lrp4* | 2 models | Alliance of Genome Resources | |||
short-rib thoracic dysplasia 7 with or without polydactyly | WDR35* | Wdr35* | 1 model | Alliance of Genome Resources | |||
short-rib thoracic dysplasia 9 with or without polydactyly | IFT140* | Ift140* | 1 model | Alliance of Genome Resources | |||
sick sinus syndrome | SCN5A* | Scn5a* | 2 models | Alliance of Genome Resources | |||
Silverman-Handmaker type dyssegmental dysplasia | HSPG2* | Hspg2* | 2 models | Alliance of Genome Resources | |||
Smith-McCort dysplasia 2 | RAB33B* | Rab33b* | 2 models | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX5* | Dlx5* | 2 models | Alliance of Genome Resources | |||
spondylocarpotarsal synostosis syndrome | FLNB* | Flnb* | 2 models | Alliance of Genome Resources | |||
spondyloepimetaphyseal dysplasia, Pakistani type | PAPSS2* | Papss2* | 1 model | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | COL2A1* | Col2a1* | 7 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | C4A*, C4B*, C4B_2 | C4b*, C4a | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | DNASE1* | Dnase1* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | FAS* | Fas* | 5 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | FCGR2A*, FCGR2B*, FCGR2C | Fcgr2b*, Fcgr3 | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | PDCD1* | Pdcd1* | 2 models | Alliance of Genome Resources | |||
systemic scleroderma | FBN1* | Fbn1* | 3 models | Alliance of Genome Resources | |||
thanatophoric dysplasia | FGFR3* | Fgfr3* | 4 models | Alliance of Genome Resources | |||
tibial muscular dystrophy | TTN* | Ttn* | 1 model | Alliance of Genome Resources | |||
tubular aggregate myopathy 1 | STIM1* | Stim1* | 2 models | Alliance of Genome Resources | |||
vascular type Ehlers-Danlos syndrome | COL3A1* | Col3a1* | 2 models | Alliance of Genome Resources | |||
Walker-Warburg syndrome | POMGNT1* | Pomgnt1* | 2 models | Alliance of Genome Resources | |||
X-linked dominant hypophosphatemic rickets | PHEX* | Phex* | 20 models | Alliance of Genome Resources | |||
achondroplasia | PTHLH | Pthlh* | 1 model | Alliance of Genome Resources | |||
achondroplasia | NPR2 | Npr2* | 3 models | Alliance of Genome Resources | |||
achondroplasia | NPPC | Nppc* | 2 models | Alliance of Genome Resources | |||
achondroplasia | ACAN | Acan* | 1 model | Alliance of Genome Resources | |||
achondroplasia | SPRED2 | Spred2* | 1 model | Alliance of Genome Resources | |||
alopecia areata | CCHCR1 | Cchcr1* | 1 model | Alliance of Genome Resources | |||
arterial tortuosity syndrome | MUS81 | Mus81* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy | srt* | 1 model | |||||
asphyxiating thoracic dystrophy | SMARCAD1 | Smarcad1* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 1 | IFT140 | Ift140* | 1 model | Alliance of Genome Resources | |||
asphyxiating thoracic dystrophy 3 | IFT80 | Ift80* | 1 model | Alliance of Genome Resources | |||
autosomal recessive hypophosphatemic rickets | DMP1 | Dmp1* | 1 model | Alliance of Genome Resources | |||
autosomal recessive osteopetrosis 1 | CCDC154 | Ccdc154* | 1 model | Alliance of Genome Resources | |||
bone development disease | NPR2 | Npr2* | 1 model | Alliance of Genome Resources | |||
bone disease | NPR3 | Npr3* | 1 model | Alliance of Genome Resources | |||
bone remodeling disease | IDH2 | Idh2* | 1 model | Alliance of Genome Resources | |||
bone structure disease | POSTN | Postn* | 1 model | Alliance of Genome Resources | |||
bone structure disease | QRFPR | Qrfpr*, Qrfprl | 1 model | Alliance of Genome Resources | |||
Camurati-Engelmann disease | MITF | Mitf* | 1 model | Alliance of Genome Resources | |||
centronuclear myopathy | PLN | Pln* | 1 model | Alliance of Genome Resources | |||
centronuclear myopathy | DNM2 | Dnm2* | 1 model | Alliance of Genome Resources | |||
centronuclear myopathy | KLHL31 | Klhl31* | 1 model | Alliance of Genome Resources | |||
centronuclear myopathy | MTM1 | Mtm1* | 1 model | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease intermediate type | CFAP276 | Cfap276* | 2 models | Alliance of Genome Resources | |||
Charcot-Marie-Tooth disease type 6 | SLC25A46 | Slc25a46* | 1 model | Alliance of Genome Resources | |||
chronic recurrent multifocal osteomyelitis | PSTPIP2 | Pstpip2* | 1 model | Alliance of Genome Resources | |||
cleidocranial dysplasia | Ccd* | 2 models | |||||
clubfoot | FKBP8 | Fkbp8* | 1 model | Alliance of Genome Resources | |||
clubfoot | TCIRG1 | Tcirg1* | 1 model | Alliance of Genome Resources | |||
clubfoot | cl* | 1 model | |||||
clubfoot | GRIP1 | Grip1* | 1 model | Alliance of Genome Resources | |||
clubfoot | pma* | 1 model | |||||
clubfoot | FRAS1 | Fras1* | 1 model | Alliance of Genome Resources | |||
clubfoot | RET | Ret* | 1 model | Alliance of Genome Resources | |||
clubfoot | vsd* | 1 model | |||||
clubfoot | Dbf* | 1 model | |||||
clubfoot | skc3* | 1 model | |||||
congenital diaphragmatic hernia | WT1 | Wt1* | 2 models | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | b2b1528Clo* | 1 model | |||||
congenital diaphragmatic hernia | GATA4 | Gata4* | 2 models | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | SOX7 | Sox7* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | SLIT3 | Slit3* | 4 models | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | PDGFRA | Pdgfra* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | NR2F2 | Nr2f2* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | NDST1 | Ndst1* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | LRP1 | Lrp1* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | KIF7 | Kif7* | 1 model | Alliance of Genome Resources | |||
congenital diaphragmatic hernia | hpld* | 1 model | |||||
congenital generalized lipodystrophy type 2 | PPARG | Pparg* | 2 models | Alliance of Genome Resources | |||
congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
congenital myopathy | MYBPC1 | Mybpc1* | 1 model | Alliance of Genome Resources | |||
congenital myopathy | LDB3 | Ldb3* | 1 model | Alliance of Genome Resources | |||
connective tissue disease | n-TUtca2* | 1 model | |||||
craniometaphyseal dysplasia | ANKH | Ank* | 1 model | Alliance of Genome Resources | |||
craniosynostosis | AXIN2 | Axin2* | 1 model | Alliance of Genome Resources | |||
Crouzon syndrome | Bey* | 1 model | |||||
cutaneous lupus erythematosus | TREX1 | Trex1* | 1 model | Alliance of Genome Resources | |||
dermatomyositis | ANGPTL2 | Angptl2* | 1 model | Alliance of Genome Resources | |||
distal arthrogryposis | TNNI2 | Tnni2* | 2 models | Alliance of Genome Resources | |||
distal arthrogryposis | ECEL1 | Ecel1* | 2 models | Alliance of Genome Resources | |||
distal arthrogryposis | FBN2 | Fbn2* | 4 models | Alliance of Genome Resources | |||
distal arthrogryposis | b2b2966Clo* | 1 model | |||||
distal myopathy | DYSF | Dysf* | 4 models | Alliance of Genome Resources | |||
distal myopathy | DNAJB4 | Dnajb4* | 2 models | Alliance of Genome Resources | |||
Duchenne muscular dystrophy | CTSS | Ctss* | 1 model | Alliance of Genome Resources | |||
dysostosis | KIF3A | Kif3a* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome | PLOD1 | Plod1* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome | DCN | Dcn* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome | COL1A1 | Col1a1* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | COL5A2 | Col5a2* | 1 model | Alliance of Genome Resources | |||
Ehlers-Danlos syndrome classic type 1 | LUM | Lum* | 2 models | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | ZMPSTE24 | Zmpste24* | 1 model | Alliance of Genome Resources | |||
Emery-Dreifuss muscular dystrophy | SYNE1 | Syne1* | 1 model | Alliance of Genome Resources | |||
facioscapulohumeral muscular dystrophy | FAT1 | Fat1* | 3 models | Alliance of Genome Resources | |||
facioscapulohumeral muscular dystrophy | LARGE1 | Large1* | 1 model | Alliance of Genome Resources | |||
familial partial lipodystrophy | PPARG | Pparg* | 3 models | Alliance of Genome Resources | |||
familial partial lipodystrophy | ZMPSTE24 | Zmpste24* | 1 model | Alliance of Genome Resources | |||
fibrodysplasia ossificans progressiva | BMP4 | Bmp4* | 1 model | Alliance of Genome Resources | |||
hereditary multiple exostoses | EXT2 | Ext2* | 1 model | Alliance of Genome Resources | |||
hypertrichotic osteochondrodysplasia Cantu type | KCNJ8 | Kcnj8* | 1 model | Alliance of Genome Resources | |||
hypochondrogenesis | COL2A1 | Col2a1* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | FOSL2 | Fosl2* | 1 model | Alliance of Genome Resources | |||
idiopathic pulmonary fibrosis | TNF | Tnf* | 1 model | Alliance of Genome Resources | |||
idiopathic scoliosis | PTPN11 | Ptpn11* | 1 model | Alliance of Genome Resources | |||
idiopathic scoliosis | RUNX3 | Runx3* | 3 models | Alliance of Genome Resources | |||
idiopathic scoliosis | MBTPS1 | Mbtps1* | 1 model | Alliance of Genome Resources | |||
idiopathic scoliosis | ADGRG6 | Adgrg6* | 2 models | Alliance of Genome Resources | |||
idiopathic scoliosis | PRMT5 | Prmt5* | 1 model | Alliance of Genome Resources | |||
Kearns-Sayre syndrome | TFAM | Tfam* | 2 models | Alliance of Genome Resources | |||
Lambert-Eaton myasthenic syndrome | CACNA1A | Cacna1a* | 1 model | Alliance of Genome Resources | |||
Leri-Weill dyschondrosteosis | SHOX2 | Shox2* | 1 model | Alliance of Genome Resources | |||
limb-girdle muscular dystrophy | SGCG | Sgcg* | 1 model | Alliance of Genome Resources | |||
lipodystrophy | ATP6V0D1 | Atp6v0d1* | 1 model | Alliance of Genome Resources | |||
lipodystrophy | LPIN1 | Lpin1* | 1 model | Alliance of Genome Resources | |||
lipodystrophy | EBF1 | Ebf1* | 1 model | Alliance of Genome Resources | |||
liposarcoma | IL22 | Il22*, Il22b | 1 model | Alliance of Genome Resources | |||
Marfan syndrome | MUS81 | Mus81* | 1 model | Alliance of Genome Resources | |||
MELAS syndrome | TRNL1 | mt-Tl1* | 1 model | Alliance of Genome Resources | |||
mitochondrial myopathy | ADCK2 | Adck2* | 1 model | Alliance of Genome Resources | |||
mitochondrial myopathy | COX10 | Cox10* | 1 model | Alliance of Genome Resources | |||
multiple epiphyseal dysplasia | COMP | Comp* | 1 model | Alliance of Genome Resources | |||
multiple synostoses syndrome | FGF9 | Fgf9* | 2 models | Alliance of Genome Resources | |||
multiple synostoses syndrome | GDF5 | Gdf5* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | B4GAT1 | B4gat1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | POMGNT1 | Pomgnt1* | 1 model | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | LARGE1 | Large1* | 3 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKTN | Fktn* | 3 models | Alliance of Genome Resources | |||
muscular dystrophy-dystroglycanopathy type B1 | FKRP | Fkrp* | 2 models | Alliance of Genome Resources | |||
myofibrillar myopathy 1 | LDB3 | Ldb3* | 1 model | Alliance of Genome Resources | |||
myopathy | ASNSD1 | Asnsd1* | 1 model | Alliance of Genome Resources | |||
myopathy | DNM2 | Dnm2* | 1 model | Alliance of Genome Resources | |||
myopathy, lactic acidosis, and sideroblastic anemia | PUS1 | Pus1* | 1 model | Alliance of Genome Resources | |||
myositis | HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-K1*, H2-D1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | 1 model | Alliance of Genome Resources | |||
myotonic disease | MBNL1 | Mbnl1* | 2 models | Alliance of Genome Resources | |||
nemaline myopathy | KLHL41 | Klhl41* | 1 model | Alliance of Genome Resources | |||
neuromuscular disease | NEMF | Nemf* | 3 models | Alliance of Genome Resources | |||
osteoarthritis | TGFBR1 | Tgfbr1* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | SMAD3 | Smad3* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | MYL3 | Myl3* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | ERRFI1 | Errfi1* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | ERG | Erg* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | ENPP1 | Enpp1* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | COL11A1 | Col11a1* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | COL9A1 | Col9a1* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | BMPR1A | Bmpr1a* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | BMP7 | Bmp7* | 1 model | Alliance of Genome Resources | |||
osteoarthritis | ATP7A | Atp7a* | 1 model | Alliance of Genome Resources | |||
osteochondrodysplasia | CEBPB | Cebpb* | 1 model | Alliance of Genome Resources | |||
osteochondrodysplasia | MIR140 | Mir140* | 2 models | Alliance of Genome Resources | |||
osteochondrodysplasia | NPPC | Nppc* | 1 model | Alliance of Genome Resources | |||
osteochondrodysplasia | RNF146 | Rnf146* | 1 model | Alliance of Genome Resources | |||
osteochondrodysplasia | ATF2 | Atf2* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta | SMAD4 | Smad4* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 2 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 3 | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
osteogenesis imperfecta type 5 | SUCO | Suco* | 1 model | Alliance of Genome Resources | |||
osteopetrosis | LRRK1 | Lrrk1* | 1 model | Alliance of Genome Resources | |||
osteopetrosis | MITF | Mitf* | 1 model | Alliance of Genome Resources | |||
osteopetrosis | CSF1 | Csf1* | 1 model | Alliance of Genome Resources | |||
osteoporosis | IFNGR1 | Ifngr1* | 1 model | Alliance of Genome Resources | |||
osteoporosis | CIITA | Ciita* | 1 model | Alliance of Genome Resources | |||
osteoporosis | ID4 | Id4* | 1 model | Alliance of Genome Resources | |||
osteoporosis | IRAK3 | Irak3* | 1 model | Alliance of Genome Resources | |||
osteoporosis | Ly6a* | 1 model | |||||
osteoporosis | PLS3 | Pls3* | 2 models | Alliance of Genome Resources | |||
osteoporosis | Terc* | 2 models | |||||
osteoporosis | TNFRSF11B | Tnfrsf11b* | 1 model | Alliance of Genome Resources | |||
osteoporosis | VDR | Vdr* | 1 model | Alliance of Genome Resources | |||
Paget's disease of bone | INPP5D | Inpp5d* | 1 model | Alliance of Genome Resources | |||
pemphigus vulgaris | DSG3 | Dsg3* | 3 models | Alliance of Genome Resources | |||
psoriasis | TTC7A | Ttc7* | 1 model | Alliance of Genome Resources | |||
psoriasis | SPTLC2 | Sptlc2* | 1 model | Alliance of Genome Resources | |||
psoriasis | S100A7, S100A7A, S100A7L2 | S100a7a* | 1 model | Alliance of Genome Resources | |||
psoriasis | ITGB2 | Itgb2*, Itgb2l | 5 models | Alliance of Genome Resources | |||
psoriasis | ARPC4 | Arpc4* | 1 model | Alliance of Genome Resources | |||
rheumatoid arthritis | ZFP36 | Zfp36* | 1 model | Alliance of Genome Resources | |||
rheumatoid arthritis | ZAP70 | Zap70* | 1 model | Alliance of Genome Resources | |||
rheumatoid arthritis | MMP14 | Mmp14* | 1 model | Alliance of Genome Resources | |||
rheumatoid arthritis | IL6ST | Il6st* | 1 model | Alliance of Genome Resources | |||
rheumatoid arthritis | DNASE2 | Dnase2a* | 2 models | Alliance of Genome Resources | |||
rickets | FAM20C | Fam20c* | 1 model | Alliance of Genome Resources | |||
scapuloperoneal myopathy | FHL1 | Fhl1* | 1 model | Alliance of Genome Resources | |||
Scheuermann's disease | CLEC3B | Clec3b* | 1 model | Alliance of Genome Resources | |||
Scheuermann's disease | NFIX | Nfix* | 1 model | Alliance of Genome Resources | |||
scoliosis | FGFR3 | Fgfr3* | 1 model | Alliance of Genome Resources | |||
scoliosis | Hvf* | 1 model | |||||
sick sinus syndrome | HCN1 | Hcn1* | 1 model | Alliance of Genome Resources | |||
sinoatrial node disease | ANK2 | Ank2* | 1 model | Alliance of Genome Resources | |||
Smith-McCort dysplasia | DYM | Dym* | 1 model | Alliance of Genome Resources | |||
SOST-related sclerosing bone dysplasia | SOST | Sost* | 1 model | Alliance of Genome Resources | |||
spinal disease | TSC1 | Tsc1* | 1 model | Alliance of Genome Resources | |||
split hand-foot malformation | MAP3K20 | Map3k20* | 1 model | Alliance of Genome Resources | |||
split hand-foot malformation 1 | DLX6 | Dlx6* | 2 models | Alliance of Genome Resources | |||
spondyloarthropathy | ENPP1 | Enpp1* | 1 model | Alliance of Genome Resources | |||
spondyloarthropathy | TNF | Tnf* | 1 model | Alliance of Genome Resources | |||
spondylocostal dysostosis | DLL3 | Dll3* | 1 model | Alliance of Genome Resources | |||
spondylocostal dysostosis | HES7 | Hes7* | 1 model | Alliance of Genome Resources | |||
spondylocostal dysostosis | RIPPLY2 | Ripply2* | 1 model | Alliance of Genome Resources | |||
spondyloepimetaphyseal dysplasia | COL2A1 | Col2a1* | 2 models | Alliance of Genome Resources | |||
spondyloepiphyseal dysplasia congenita | HAPLN1 | Hapln1* | 1 model | Alliance of Genome Resources | |||
syndactyly | b2b1594Clo* | 1 model | |||||
synpolydactyly | HOXD13 | Hoxd13* | 3 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | RC3H1 | Rc3h1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | TRAF3IP2 | Traf3ip2* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | TNFRSF13B | Tnfrsf13b* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | TLR7 | Tlr7* | 4 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | TIMD4 | Timd4* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | RXRA | Rxra* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | RUBCN | Rubcn* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | RO60 | Ro60* | 3 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | RASSF5 | Rassf5* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | RASGRP1 | Rasgrp1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | PTPRC | Ptprc* | 3 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | PRDM1 | Prdm1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | PPARG | Pparg* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | POLB | Polb* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | PLD4 | Pld4* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | MTA2 | Mta2* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | MAN2A1 | Man2a1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | LYN | Lyn* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | LBR | Lbr* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | JUNB | Junb* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | JAK1 | Jak1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | INPP5D | Inpp5d* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | IKZF3 | Ikzf3* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | IFIH1 | Ifih1* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | GADD45A | Gadd45a* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | FAM210B | Fam210b* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | EP300 | Ep300* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | DEF6 | Def6* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | CYBB | Cybb* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | CDKN1A | Cdkn1a* | 2 models | Alliance of Genome Resources | |||
systemic lupus erythematosus | CD40LG | Cd40lg* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | C1QA | C1qa* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | BECN1 | Becn1* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | ATG7 | Atg7* | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | ATG5 | Atg5* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | FOSL2 | Fosl2* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | TGFBR1 | Tgfbr1* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | FLI1 | Fli1* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | COL3A1 | Col3a1* | 1 model | Alliance of Genome Resources | |||
thanatophoric dysplasia | HSPG2 | Hspg2* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A1 | Col6a1* | 1 model | Alliance of Genome Resources | |||
Ullrich congenital muscular dystrophy | COL6A3 | Col6a3* | 1 model | Alliance of Genome Resources | |||
Walker-Warburg syndrome | COL4A1 | Col4a1* | 1 model | Alliance of Genome Resources | |||
Weissenbacher-Zweymuller syndrome | hpmd* | 1 model | |||||
Weissenbacher-Zweymuller syndrome | ACVR2A | Acvr2a* | 1 model | Alliance of Genome Resources | |||
Weissenbacher-Zweymuller syndrome | MAPK1 | Mapk1* | 1 model | Alliance of Genome Resources | |||
Weissenbacher-Zweymuller syndrome | TFRC | Tfrc* | 1 model | Alliance of Genome Resources | |||
Weissenbacher-Zweymuller syndrome | SOX11 | Sox11* | 1 model | Alliance of Genome Resources | |||
X-linked dominant hypophosphatemic rickets | Gy* | 1 model | |||||
3-methylcrotonyl-CoA carboxylase 1 deficiency | MCCC1* | Mccc1 | Alliance of Genome Resources | ||||
3-methylcrotonyl-CoA carboxylase 2 deficiency | MCCC2* | Mccc2 | Alliance of Genome Resources | ||||
achondrogenesis type IB | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
acrocapitofemoral dysplasia | IHH* | Ihh | Alliance of Genome Resources | ||||
acrocephalosyndactylia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
acrocephalosyndactylia | TWIST1* | Twist1 | Alliance of Genome Resources | ||||
acrodysostosis | PDE4D* | Pde4d | Alliance of Genome Resources | ||||
acrofacial dysostosis Cincinnati type | POLR1A* | Polr1a | Alliance of Genome Resources | ||||
acromelic frontonasal dysostosis | ZSWIM6* | Zswim6 | Alliance of Genome Resources | ||||
acromesomelic dysplasia-3 | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
acromesomelic dysplasia-4 | PRKG2* | Prkg2 | Alliance of Genome Resources | ||||
acromicric dysplasia | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
alopecia areata | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
alopecia areata | IL18* | Il18 | Alliance of Genome Resources | ||||
alopecia areata | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
alopecia areata | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
alopecia areata | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
alopecia areata | MX1*, MX2 | Mx1, Mx2 | Alliance of Genome Resources | ||||
alopecia areata | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
alopecia areata | IL2* | Il2 | Alliance of Genome Resources | ||||
alopecia areata | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
alveolar rhabdomyosarcoma | PAX3* | Pax3 | 4 models | Alliance of Genome Resources | |||
alveolar rhabdomyosarcoma | PAX7* | Pax7 | Alliance of Genome Resources | ||||
alveolar rhabdomyosarcoma | FOXO1* | Foxo1 | Alliance of Genome Resources | ||||
alveolar soft part sarcoma | ASPSCR1* | Aspscr1 | Alliance of Genome Resources | ||||
anauxetic dysplasia 1 | RMRP* | Rmrp | Alliance of Genome Resources | ||||
anauxetic dysplasia 2 | POP1* | Pop1 | Alliance of Genome Resources | ||||
anauxetic dysplasia 3 | NEPRO* | Nepro | Alliance of Genome Resources | ||||
ankylosing spondylitis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
ankylosing spondylitis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
ankylosing spondylitis | TAP1* | Tap1 | Alliance of Genome Resources | ||||
ankylosing spondylitis | PTGER4* | Ptger4 | Alliance of Genome Resources | ||||
ankylosing spondylitis | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
ankylosing spondylitis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
ankylosing spondylitis | KDM5A* | Kdm5a | Alliance of Genome Resources | ||||
ankylosing spondylitis | JAK2* | Jak2 | Alliance of Genome Resources | ||||
ankylosing spondylitis | IRAK1* | Irak1 | Alliance of Genome Resources | ||||
ankylosing spondylitis | IL23R* | Il23r | Alliance of Genome Resources | ||||
ankylosing spondylitis | IL17A* | Il17a | Alliance of Genome Resources | ||||
ankylosing spondylitis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
ankylosing spondylitis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
ankylosing spondylitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
ankylosing spondylitis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
ankylosing spondylitis | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
ankylosing spondylitis | ASPN* | Aspn | Alliance of Genome Resources | ||||
ankylosing spondylitis | ANO6* | Ano6 | Alliance of Genome Resources | ||||
ankylosing spondylitis | ACE* | Ace | Alliance of Genome Resources | ||||
Antley-Bixler syndrome | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
Antley-Bixler syndrome with disordered steroidogenesis | POR* | Por | Alliance of Genome Resources | ||||
Antley-Bixler syndrome without disordered steroidogenesis | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
arterial tortuosity syndrome | SLC2A10* | Slc2a10 | 2 "NOT" models | Alliance of Genome Resources | |||
arterial tortuosity syndrome | EFEMP2* | Efemp2 | Alliance of Genome Resources | ||||
arthritis | GC* | Gc | Alliance of Genome Resources | ||||
arthritis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
arthritis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
arthritis | B2M* | B2m | Alliance of Genome Resources | ||||
arthritis | PARP1* | Parp1 | Alliance of Genome Resources | ||||
arthritis | IL23R* | Il23r | Alliance of Genome Resources | ||||
arthritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
arthritis | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
arthritis | CD40* | Cd40 | Alliance of Genome Resources | ||||
arthropathy | TBX4* | Tbx4 | Alliance of Genome Resources | ||||
arthropathy | CCN6* | Ccn6 | Alliance of Genome Resources | ||||
asbestosis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
asbestosis | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | DYNLT2B* | Dynlt2b | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | KIAA0753* | 4933427D14Rik | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | DYNC2H1* | Dync2h1 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | DYNC2LI1* | Dync2li1 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | IFT52* | Ift52 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | INTU* | Intu | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy | NEK1* | Nek1 | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy 4 | TTC21B* | Ttc21b | Alliance of Genome Resources | ||||
asphyxiating thoracic dystrophy 5 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
atelosteogenesis | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
atelosteogenesis | FLNB* | Flnb | Alliance of Genome Resources | ||||
autosomal dominant craniodiaphyseal dysplasia | SOST* | Sost | Alliance of Genome Resources | ||||
autosomal dominant craniometaphyseal dysplasia | ANKH* | Ank | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 5 | SYNE2* | Syne2 | Alliance of Genome Resources | ||||
autosomal dominant Emery-Dreifuss muscular dystrophy 7 | TMEM43* | Tmem43 | Alliance of Genome Resources | ||||
autosomal dominant hyaline body myopathy | MYH7* | Myh7 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 1 | DNAJB6* | Dnajb6 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 2 | TNPO3* | Tnpo3 | Alliance of Genome Resources | ||||
autosomal dominant limb-girdle muscular dystrophy type 3 | HNRNPDL* | Hnrnpdl | Alliance of Genome Resources | ||||
autosomal dominant osteopetrosis 1 | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia 1 | POLG* | Polg | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | TWNK* | Twnk | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | POLG2* | Polg2 | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | RRM2B* | Rrm2b | Alliance of Genome Resources | ||||
autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 6 | DNA2* | Dna2 | Alliance of Genome Resources | ||||
autosomal recessive craniometaphyseal dysplasia | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
autosomal recessive Emery-Dreifuss muscular dystrophy 3 | LMNA* | Lmna | Alliance of Genome Resources | ||||
autosomal recessive hyaline body myopathy | MYH7* | Myh7 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | POPDC3* | Popdc3 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | JAG2* | Jag2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2D | DAG1* | Dag1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2K | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2L | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2M | FKTN* | Fktn | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2N | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2O | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Q | PLEC* | Plec | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2S | TRAPPC11* | Trappc11 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2T | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2W | LIMS2* | Lims2 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2X | POPDC1* | Bves | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Y | TOR1AIP1* | Tor1aip1 | Alliance of Genome Resources | ||||
autosomal recessive limb-girdle muscular dystrophy type 2Z | POGLUT1* | Poglut1 | Alliance of Genome Resources | ||||
autosomal recessive osteopetrosis 7 | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia 1 | POLG* | Polg | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | RNASEH1* | Rnaseh1 | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | TK2* | Tk2 | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | DGUOK* | Dguok | Alliance of Genome Resources | ||||
autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | TOP3A* | Top3a | Alliance of Genome Resources | ||||
axial spondylometaphyseal dysplasia | CFAP410* | Cfap410 | Alliance of Genome Resources | ||||
Baller-Gerold syndrome | RECQL4* | Recql4 | Alliance of Genome Resources | ||||
Becker disease | CLCN1* | Clcn1 | Alliance of Genome Resources | ||||
berylliosis | BTNL2* | Btnl2 | Alliance of Genome Resources | ||||
berylliosis | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
berylliosis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
Bethlem myopathy | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
Beukes hip dysplasia | UFSP2* | Ufsp2 | Alliance of Genome Resources | ||||
bone development disease | FLNB* | Flnb | Alliance of Genome Resources | ||||
bone development disease | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
bone disease | EPHX1* | Ephx1 | Alliance of Genome Resources | ||||
bone disease | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
Boomerang dysplasia | FLNB* | Flnb | Alliance of Genome Resources | ||||
brachydactyly | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
brachydactyly type A1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
brachydactyly type A1D | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
brachydactyly type A2 | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
brachydactyly type A4 | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly type B1 | ROR2* | Ror2 | 1 "NOT" model | Alliance of Genome Resources | |||
brachydactyly type B2 | NOG* | Nog | Alliance of Genome Resources | ||||
brachydactyly type D | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly type E1 | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
brachydactyly type E2 | PTHLH* | Pthlh | Alliance of Genome Resources | ||||
brittle cornea syndrome 2 | PRDM5* | Prdm5 | Alliance of Genome Resources | ||||
Brody myopathy | ATP2A1* | Atp2a1 | Alliance of Genome Resources | ||||
bronchiolitis obliterans | NOD2* | Nod2 | Alliance of Genome Resources | ||||
bronchiolitis obliterans | EDN1* | Edn1 | Alliance of Genome Resources | ||||
bronchiolitis obliterans | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
bronchiolitis obliterans | TLR9* | Tlr9 | Alliance of Genome Resources | ||||
bullous pemphigoid | IL2* | Il2 | Alliance of Genome Resources | ||||
Caffey disease | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
calvarial doughnut lesions with bone fragility | SGMS2* | Sgms2 | Alliance of Genome Resources | ||||
Camurati-Engelmann disease | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
Carpenter syndrome | RAB23* | Rab23 | Alliance of Genome Resources | ||||
cartilage disease | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
Catel Manzke syndrome | TGDS* | Tgds | Alliance of Genome Resources | ||||
Cenani-Lenz syndactyly syndrome | LRP4* | Lrp4 | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | MTMR14* | Mtmr14 | Alliance of Genome Resources | ||||
centronuclear myopathy 1 | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
centronuclear myopathy 2 | BIN1* | Bin1 | Alliance of Genome Resources | ||||
centronuclear myopathy 4 | CCDC78* | Ccdc78 | Alliance of Genome Resources | ||||
centronuclear myopathy 5 | SPEG* | Speg | Alliance of Genome Resources | ||||
centronuclear myopathy 6 with fiber-type disproportion | MAP3K20* | Map3k20 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | CADM3* | Cadm3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | SLC12A6* | Slc12a6 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | POLR3B* | Polr3b | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | PMP22* | Pmp22 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | NRG1* | Nrg1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | FBLN5* | Fbln5 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | JAG1* | Jag1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease | ITPR3* | Itpr3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2C | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2CC | NEFH* | Nefh | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2F | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2K | JPH1* | Jph1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2L | HSPB8* | Hspb8 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2N | AARS1* | Aars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2T | MME* | Mme | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2U | MARS1* | Mars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2V | NAGLU* | Naglu | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease, axonal type 2W | HARS1* | Hars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease axonal type 2X | SPG11* | Spg11 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate A | GBF1* | Gbf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate B | DNM2* | Dnm2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate D | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate E | INF2* | Inf2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate F | GNB4* | Gnb4 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease dominant intermediate G | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate B | KARS1* | Kars1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease recessive intermediate C | PLEKHG5* | Plekhg5 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1D | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1F | NEFL* | Nefl | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 1G | PMP2* | Pmp2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2A2B | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2B2 | PNKP* | Pnkp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2DD | ATP1A1* | Atp1a1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2EE | MPV17* | Mpv17 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2I | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2J | MPZ* | Mpz | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2R | TRIM2* | Trim2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 2Y | VCP* | Vcp | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | EGR2* | Egr2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 3 | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4A | GDAP1* | Gdap1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4F | PRX* | Prx | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4G | HK1* | Hk1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 4K | SURF1* | Surf1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease type 6 | MFN2* | Mfn2 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked dominant 6 | PDK3* | Pdk3 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked recessive 4 | AIFM1* | Aifm1 | Alliance of Genome Resources | ||||
Charcot-Marie-Tooth disease X-linked recessive 5 | PRPS1* | Prps1 | Alliance of Genome Resources | ||||
Chilblain lupus | SAMHD1* | Samhd1 | Alliance of Genome Resources | ||||
Chilblain lupus | TREX1* | Trex1 | Alliance of Genome Resources | ||||
chondrocalcinosis | ANKH* | Ank | Alliance of Genome Resources | ||||
chondrodysplasia Blomstrand type | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
chondrosarcoma | EXT1* | Ext1 | Alliance of Genome Resources | ||||
chondrosarcoma | TAF15* | Taf15 | Alliance of Genome Resources | ||||
chondrosarcoma | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
chronic progressive external ophthalmoplegia | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
chronic progressive external ophthalmoplegia | RRM1* | Rrm1 | Alliance of Genome Resources | ||||
chronic progressive external ophthalmoplegia | TWNK* | Twnk | Alliance of Genome Resources | ||||
chronic progressive external ophthalmoplegia | POLG* | Polg | Alliance of Genome Resources | ||||
chronic recurrent multifocal osteomyelitis | LPIN2* | Lpin2 | Alliance of Genome Resources | ||||
chronic recurrent multifocal osteomyelitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
chronic recurrent multifocal osteomyelitis | IL1R1* | Il1r1 | Alliance of Genome Resources | ||||
cicatricial pemphigoid | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
cicatricial pemphigoid | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
clubfoot | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
clubfoot | FLNB* | Flnb | Alliance of Genome Resources | ||||
clubfoot | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
clubfoot | HOXD12* | Hoxd12 | Alliance of Genome Resources | ||||
Cole-Carpenter syndrome | P4HB* | P4hb | Alliance of Genome Resources | ||||
Cole-Carpenter syndrome | SEC24D* | Sec24d | Alliance of Genome Resources | ||||
congenital contractural arachnodactyly | FBN2* | Fbn2 | Alliance of Genome Resources | ||||
congenital diaphragmatic hernia | ALDH1A2* | Aldh1a2 | Alliance of Genome Resources | ||||
congenital diaphragmatic hernia | MYRF* | Myrf | Alliance of Genome Resources | ||||
congenital generalized lipodystrophy | PCYT1A* | Pcyt1a | Alliance of Genome Resources | ||||
congenital generalized lipodystrophy type 3 | CAV1* | Cav1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy A7 | CRPPA* | Crppa | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A1 | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A10 | RXYLT1* | Rxylt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A11 | B3GALNT2* | B3galnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A12 | POMK* | Pomk | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A13 | B4GAT1* | B4gat1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A5 | FKRP* | Fkrp | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A6 | LARGE1* | Large1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
congenital muscular dystrophy-dystroglycanopathy type A9 | DAG1* | Dag1 | Alliance of Genome Resources | ||||
congenital muscular dystrophy with cataracts and intellectual disability | INPP5K* | Inpp5k | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | VAMP1* | Vamp1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | SLC25A1* | Slc25a1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | CHRNE* | Chrne | Alliance of Genome Resources | ||||
congenital myasthenic syndrome | MYO9A* | Myo9a | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 13 | DPAGT1* | Dpagt1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 14 | ALG2* | Alg2 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 15 | ALG14* | Alg14 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 16 | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 17 | LRP4* | Lrp4 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 18 | SNAP25* | Snap25 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1A | CAST* | Cast | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 1B | CHRNA1* | Chrna1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 20 | SLC5A7* | Slc5a7 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 21 | SLC18A3* | Slc18a3 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 22 | PREPL* | Prepl | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2A | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 2C | CHRNB1* | Chrnb1 | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3B | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 3C | CHRND* | Chrnd | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 4B | CHRNE* | Chrne | Alliance of Genome Resources | ||||
congenital myasthenic syndrome 7 | SYT2* | Syt2 | Alliance of Genome Resources | ||||
congenital myopathy | HACD1* | Hacd1 | Alliance of Genome Resources | ||||
congenital myopathy 10B | MEGF10* | Megf10 | Alliance of Genome Resources | ||||
congenital myopathy 14 | MYL1* | Myl1 | Alliance of Genome Resources | ||||
congenital myopathy 15 | TNNC2* | Tnnc2 | Alliance of Genome Resources | ||||
congenital myopathy 16 | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
congenital myopathy 17 | MYOD1* | Myod1 | Alliance of Genome Resources | ||||
congenital myopathy 18 | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
congenital myopathy 19 | PAX7* | Pax7 | Alliance of Genome Resources | ||||
congenital myopathy 20 | RYR3* | Ryr3 | Alliance of Genome Resources | ||||
congenital myopathy 21 | DNAJB4* | Dnajb4 | Alliance of Genome Resources | ||||
congenital myopathy 22A | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myopathy 22B | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
congenital myopathy 2B | ACTA1* | Acta1 | Alliance of Genome Resources | ||||
congenital myopathy 2C | ACTA1* | Acta1 | Alliance of Genome Resources | ||||
congenital myopathy 4A | TPM3* | Tpm3 | Alliance of Genome Resources | ||||
congenital myopathy 5 | TTN* | Ttn | Alliance of Genome Resources | ||||
congenital myopathy 6 | MYH2* | Myh2 | Alliance of Genome Resources | ||||
congenital myopathy 8 | ACTN2* | Actn2 | Alliance of Genome Resources | ||||
congenital myopathy 9A | FXR1* | Fxr1 | Alliance of Genome Resources | ||||
congenital myopathy 9B | FXR1* | Fxr1 | Alliance of Genome Resources | ||||
congenital structural myopathy | MTM1* | Mtm1 | Alliance of Genome Resources | ||||
congenital structural myopathy | MYF6* | Myf6 | Alliance of Genome Resources | ||||
congenital structural myopathy | ANKRD1* | Ankrd1 | Alliance of Genome Resources | ||||
congenital vertical talus | HOXD10* | Hoxd10 | Alliance of Genome Resources | ||||
connective tissue disease | SNRPD1* | Snrpd1 | Alliance of Genome Resources | ||||
connective tissue disease | SNRPA* | Snrpa | Alliance of Genome Resources | ||||
connective tissue disease | SNRPA1* | Snrpa1 | Alliance of Genome Resources | ||||
connective tissue disease | SNRPB2* | Snrpb2 | Alliance of Genome Resources | ||||
connective tissue disease | SNRPC* | Snrpc | Alliance of Genome Resources | ||||
craniosynostosis | ZIC1* | Zic1 | Alliance of Genome Resources | ||||
craniosynostosis | ALX4* | Alx4 | Alliance of Genome Resources | ||||
craniosynostosis | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
craniosynostosis | ERF* | Erf | Alliance of Genome Resources | ||||
craniosynostosis | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
craniosynostosis | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
craniosynostosis | FLNA* | Flna | Alliance of Genome Resources | ||||
craniosynostosis | NOG* | Nog | Alliance of Genome Resources | ||||
craniosynostosis | TCF12* | Tcf12 | Alliance of Genome Resources | ||||
craniosynostosis | TWIST1* | Twist1 | Alliance of Genome Resources | ||||
craniosynostosis 7 | SMAD6* | Smad6 | Alliance of Genome Resources | ||||
Crouzon syndrome-acanthosis nigricans syndrome | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
cystic echinococcosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
cystic echinococcosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
cystic echinococcosis | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
degenerative disc disease | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
degenerative disc disease | ASPN* | Aspn | Alliance of Genome Resources | ||||
dermatofibrosarcoma protuberans | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
dermatofibrosarcoma protuberans | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
dermatomyositis | STAT4* | Stat4 | Alliance of Genome Resources | ||||
dermatomyositis | PMS1* | Pms1 | Alliance of Genome Resources | ||||
dermatomyositis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
Desbuquois dysplasia | XYLT1* | Xylt1 | Alliance of Genome Resources | ||||
developmental dysplasia of the hip 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
diaphyseal medullary stenosis with malignant fibrous histiocytoma | MTAP* | Mtap | Alliance of Genome Resources | ||||
diffuse scleroderma | IRAK1* | Irak1 | Alliance of Genome Resources | ||||
diffuse scleroderma | WRN* | Wrn | Alliance of Genome Resources | ||||
diffuse scleroderma | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
diffuse scleroderma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
diffuse scleroderma | TAP1* | Tap1 | Alliance of Genome Resources | ||||
diffuse scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
diffuse scleroderma | BANK1* | Bank1 | Alliance of Genome Resources | ||||
diffuse scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
diffuse scleroderma | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
diffuse scleroderma | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
diffuse scleroderma | IL13* | Il13 | Alliance of Genome Resources | ||||
disabling pansclerotic morphea | STAT4* | Stat4 | Alliance of Genome Resources | ||||
distal arthrogryposis | ADAMTS15* | Adamts15 | Alliance of Genome Resources | ||||
distal arthrogryposis | MET* | Met | Alliance of Genome Resources | ||||
distal arthrogryposis type 1A | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1B | MYBPC1* | Mybpc1 | Alliance of Genome Resources | ||||
distal arthrogryposis type 1C | MYL11* | Mylpf | Alliance of Genome Resources | ||||
distal arthrogryposis type 2A | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B | TNNT3* | Tnnt3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B1 | TNNI2* | Tnni2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B2 | TNNT3* | Tnnt3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 2B3 | MYH3* | Myh3 | Alliance of Genome Resources | ||||
distal arthrogryposis type 3 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 5 | PIEZO2* | Piezo2 | Alliance of Genome Resources | ||||
distal arthrogryposis type 5D | ECEL1* | Ecel1 | Alliance of Genome Resources | ||||
distal arthrogryposis type 7 | MYH8* | Myh8 | Alliance of Genome Resources | ||||
distal myopathy | LDB3* | Ldb3 | Alliance of Genome Resources | ||||
distal myopathy 1 | MYH7* | Myh7 | Alliance of Genome Resources | ||||
distal myopathy 3 | HNRNPA1*, HNRNPA1L2 | Hnrnpa1, Hnrnpa1l2-ps2 | Alliance of Genome Resources | ||||
distal myopathy 4 | FLNC* | Flnc | Alliance of Genome Resources | ||||
distal myopathy Tateyama type | CAV3* | Cav3 | Alliance of Genome Resources | ||||
distal myopathy with anterior tibial onset | DYSF* | Dysf | Alliance of Genome Resources | ||||
distal myopathy with rimmed vacuoles | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
Duchenne muscular dystrophy | DAG1* | Dag1 | Alliance of Genome Resources | ||||
Duchenne muscular dystrophy | ITGA7* | Itga7 | 1 model | Alliance of Genome Resources | |||
Dyggve-Melchior-Clausen disease | DYM* | Dym | Alliance of Genome Resources | ||||
dysostosis | DLL3* | Dll3 | Alliance of Genome Resources | ||||
dysostosis | EFNB1* | Efnb1 | Alliance of Genome Resources | ||||
early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome | MEGF10* | Megf10 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | COL3A1* | Col3a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | ADAMTS2* | Adamts2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | B4GALT7* | B4galt7 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | TNXB* | Tnxb | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | SLC39A13* | Slc39a13 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | LOX* | Lox | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | COL5A2* | Col5a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | COL5A1* | Col5a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 1 | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome arthrochalasia type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome cardiac valvular type | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome classic-like 2 | AEBP1* | Aebp1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome classic type 2 | COL5A2* | Col5a2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome dermatosparaxis type | ADAMTS2* | Adamts2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome hypermobility type | COL3A1* | Col3a1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome kyphoscoliotic type 1 | PLOD1* | Plod1 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome kyphoscoliotic type 2 | FKBP14* | Fkbp14 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome musculocontractural type 1 | CHST14* | Chst14 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome musculocontractural type 2 | DSE* | Dse | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 1 | C1R* | C1ra, C1rb | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome periodontal type 2 | C1S* | C1s1, C1s2 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome spondylodysplastic type 1 | B4GALT7* | B4galt7 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome spondylodysplastic type 2 | B3GALT6* | B3galt6 | Alliance of Genome Resources | ||||
Ehlers-Danlos syndrome spondylodysplastic type 3 | SLC39A13* | Slc39a13 | Alliance of Genome Resources | ||||
Eiken syndrome | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
Emery-Dreifuss muscular dystrophy | EMD* | Emd | Alliance of Genome Resources | ||||
erythema nodosum | LTA* | Lta | Alliance of Genome Resources | ||||
erythema nodosum | VDR* | Vdr | Alliance of Genome Resources | ||||
erythema nodosum | TNF* | Tnf | Alliance of Genome Resources | ||||
erythema nodosum | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
erythema nodosum | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
Ewing sarcoma | EWSR1* | Ewsr1 | Alliance of Genome Resources | ||||
extraskeletal myxoid chondrosarcoma | TAF15* | Taf15 | Alliance of Genome Resources | ||||
extraskeletal myxoid chondrosarcoma | NR4A3* | Nr4a3 | Alliance of Genome Resources | ||||
extrinsic allergic alveolitis | TNF* | Tnf | Alliance of Genome Resources | ||||
extrinsic allergic alveolitis | TAP1* | Tap1 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 2 | SMCHD1* | Smchd1 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 3 | LRIF1* | Lrif1 | Alliance of Genome Resources | ||||
facioscapulohumeral muscular dystrophy 4 | DNMT3B* | Dnmt3b | Alliance of Genome Resources | ||||
familial expansile osteolysis | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
familial partial lipodystrophy | ADRA2A* | Adra2a | Alliance of Genome Resources | ||||
familial partial lipodystrophy | CAV1* | Cav1 | Alliance of Genome Resources | ||||
familial partial lipodystrophy | LMNA* | Lmna | 2 "NOT" models | Alliance of Genome Resources | |||
familial partial lipodystrophy type 2 | LMNA* | Lmna | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 3 | PPARG* | Pparg | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 4 | PLIN1* | Plin1 | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 5 | CIDEC* | Cidec | Alliance of Genome Resources | ||||
familial partial lipodystrophy type 6 | LIPE* | Lipe | Alliance of Genome Resources | ||||
farmer's lung | TNF* | Tnf | Alliance of Genome Resources | ||||
fatal infantile hypertonic myofibrillar myopathy | CRYAB* | Cryab | Alliance of Genome Resources | ||||
fibrochondrogenesis 1 | COL11A1* | Col11a1 | Alliance of Genome Resources | ||||
fibrochondrogenesis 2 | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
fibroma | ANTXR2* | Antxr2 | Alliance of Genome Resources | ||||
fibrosarcoma | CDC42* | Cdc42 | Alliance of Genome Resources | ||||
fibrosarcoma | TNFRSF1A* | Tnfrsf1a | Alliance of Genome Resources | ||||
Frank-Ter Haar syndrome | SH3PXD2B* | Sh3pxd2b | Alliance of Genome Resources | ||||
frontometaphyseal dysplasia | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
frontometaphyseal dysplasia 1 | FLNA* | Flna | Alliance of Genome Resources | ||||
frontometaphyseal dysplasia 2 | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
geleophysic dysplasia 2 | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
geleophysic dysplasia 3 | LTBP3* | Ltbp3 | Alliance of Genome Resources | ||||
glomus tumor | GLMN* | Glmn | Alliance of Genome Resources | ||||
GNE myopathy | GNE* | Gne | Alliance of Genome Resources | ||||
gout | SLC17A3* | Slc17a3 | Alliance of Genome Resources | ||||
gout | HP*, HPR | Hp | Alliance of Genome Resources | ||||
gout | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
gout | ABCG2* | Abcg2, Abcg3 | Alliance of Genome Resources | ||||
gout | A1CF* | A1cf | Alliance of Genome Resources | ||||
gout | PRPS1* | Prps1 | Alliance of Genome Resources | ||||
Hailey-Hailey disease | ATP2C1* | Atp2c1 | 1 "NOT" model | Alliance of Genome Resources | |||
hereditary hypophosphatemic rickets with hypercalciuria | SLC34A3* | Slc34a3 | 1 model | Alliance of Genome Resources | |||
hyaline fibromatosis syndrome | ANTXR2* | Antxr2 | Alliance of Genome Resources | ||||
idiopathic juvenile osteoporosis | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | BRD4* | Brd4 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SETD2* | Setd2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | TERT* | Tert | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | EHMT2* | Ehmt2 | Alliance of Genome Resources | ||||
idiopathic pulmonary fibrosis | CXCL5*, CXCL6 | Cxcl5 | Alliance of Genome Resources | ||||
inclusion body myositis | VCP* | Vcp | Alliance of Genome Resources | ||||
inclusion body myositis | TUBG1* | Tubg1 | Alliance of Genome Resources | ||||
inclusion body myositis | SOD2* | Sod2 | Alliance of Genome Resources | ||||
inclusion body myositis | MYH2* | Myh2 | Alliance of Genome Resources | ||||
inclusion body myositis | DAG1* | Dag1 | Alliance of Genome Resources | ||||
inclusion body myositis | CLU* | Clu | Alliance of Genome Resources | ||||
infantile myofibromatosis | NOTCH3* | Notch3 | Alliance of Genome Resources | ||||
interstitial lung disease | SFTPC* | Sftpc | Alliance of Genome Resources | ||||
interstitial lung disease | IL4R* | Il4ra | Alliance of Genome Resources | ||||
interstitial lung disease | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
interstitial lung disease | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
interstitial lung disease | SFTPB* | Sftpb | Alliance of Genome Resources | ||||
interstitial lung disease | AP3B1* | Ap3b1 | Alliance of Genome Resources | ||||
interstitial lung disease | IL2* | Il2 | Alliance of Genome Resources | ||||
interstitial lung disease | IL1A* | Il1a | Alliance of Genome Resources | ||||
interstitial lung disease | HGF* | Hgf | Alliance of Genome Resources | ||||
interstitial lung disease 1 | SFTPA1*, SFTPA2 | Sftpa1 | Alliance of Genome Resources | ||||
interstitial lung disease 2 | MUC5B* | Muc5b | Alliance of Genome Resources | ||||
interstitial lung disease 2 | SFTPA2*, SFTPA1 | Sftpa1 | Alliance of Genome Resources | ||||
ischiocoxopodopatellar syndrome | TBX4* | Tbx4 | Alliance of Genome Resources | ||||
Jansen's metaphyseal chondrodysplasia | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | HFE* | Hfe | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | IL1A* | Il1a | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | LACC1* | Lacc1 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | SH2D2A* | Sh2d2a | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | CIITA* | Ciita | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
juvenile rheumatoid arthritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Kaposi's sarcoma | BPTF* | Bptf | Alliance of Genome Resources | ||||
Kaposi's sarcoma | IL6* | Il6 | Alliance of Genome Resources | ||||
Kenny-Caffey syndrome type 1 | TBCE* | Tbce | Alliance of Genome Resources | ||||
Kenny-Caffey syndrome type 2 | FAM111A* | Fam111a | Alliance of Genome Resources | ||||
King Denborough syndrome | RYR1* | Ryr1 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 1 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 2 | MEOX1* | Meox1 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 3 | GDF3* | Gdf3 | Alliance of Genome Resources | ||||
Klippel-Feil syndrome 4 | MYO18B* | Myo18b | Alliance of Genome Resources | ||||
Kniest dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
kyphosis | ELP1* | Elp1 | Alliance of Genome Resources | ||||
Lambert-Eaton myasthenic syndrome | CHRM1* | Chrm1 | Alliance of Genome Resources | ||||
Lambert-Eaton myasthenic syndrome | CACNA1B* | Cacna1b | Alliance of Genome Resources | ||||
Laurin-Sandrow syndrome | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
Legg-Calve-Perthes disease | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
leiomyosarcoma | MED12* | Med12 | Alliance of Genome Resources | ||||
Leri-Weill dyschondrosteosis | SHOX* | ||||||
limb-girdle muscular dystrophy | FKRP* | Fkrp | Alliance of Genome Resources | ||||
limited scleroderma | IL2* | Il2 | Alliance of Genome Resources | ||||
limited scleroderma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
limited scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
limited scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
lipodystrophy | BSCL2* | Bscl2 | Alliance of Genome Resources | ||||
lipodystrophy | LMNA* | Lmna | Alliance of Genome Resources | ||||
lipodystrophy | PPARG* | Pparg | Alliance of Genome Resources | ||||
lipodystrophy | AGPAT2* | Agpat2 | Alliance of Genome Resources | ||||
lipoma | HMGA2* | Hmga2 | Alliance of Genome Resources | ||||
liposarcoma | FUS* | Fus | Alliance of Genome Resources | ||||
localized osteosarcoma | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
localized scleroderma | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
localized scleroderma | HGF* | Hgf | Alliance of Genome Resources | ||||
malignant hyperthermia | CACNA1S* | Cacna1s | Alliance of Genome Resources | ||||
malignant hyperthermia | CACNG1* | Cacng1 | Alliance of Genome Resources | ||||
malignant pleural mesothelioma | CHRNA7*, CHRFAM7A | Chrna7 | Alliance of Genome Resources | ||||
malignant pleural mesothelioma | SMO* | Smo | Alliance of Genome Resources | ||||
malignant pleural mesothelioma | SETD2* | Setd2 | Alliance of Genome Resources | ||||
malignant pleural mesothelioma | NF2* | Nf2 | Alliance of Genome Resources | ||||
mandibuloacral dysplasia type A lipodystrophy | LMNA* | Lmna | Alliance of Genome Resources | ||||
mandibuloacral dysplasia type B lipodystrophy | ZMPSTE24* | Zmpste24 | Alliance of Genome Resources | ||||
Marfan syndrome | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
MELAS syndrome | COX3* | mt-Co3 | Alliance of Genome Resources | ||||
MELAS syndrome | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
MELAS syndrome | ND5* | mt-Nd5 | Alliance of Genome Resources | ||||
Melnick-Needles syndrome | FLNA* | Flna | Alliance of Genome Resources | ||||
melorheostosis | MAP2K1* | Map2k1 | Alliance of Genome Resources | ||||
metachondromatosis | PTPN11* | Ptpn11 | Alliance of Genome Resources | ||||
metaphyseal dysplasia | SFRP4* | Sfrp4 | Alliance of Genome Resources | ||||
metaphyseal dysplasia-maxillary hypoplasia-brachydactyly syndrome | RUNX2* | Runx2 | Alliance of Genome Resources | ||||
metatropic dysplasia | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
microcephalic osteodysplastic primordial dwarfism type I | RNU4ATAC* | ||||||
microcephaly, short stature, and limb abnormalities | DONSON* | Donson | Alliance of Genome Resources | ||||
mitochondrial encephalomyopathy | TYMP* | Tymp | Alliance of Genome Resources | ||||
mitochondrial encephalomyopathy | POLG* | Polg | Alliance of Genome Resources | ||||
mitochondrial myopathy | DNA2* | Dna2 | Alliance of Genome Resources | ||||
mitochondrial myopathy | SLC25A4* | Slc25a4 | Alliance of Genome Resources | ||||
mitochondrial myopathy | FDX2* | Fdx2 | Alliance of Genome Resources | ||||
Miura type epiphyseal chondrodysplasia | NPR2* | Npr2 | Alliance of Genome Resources | ||||
mixed connective tissue disease | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
mixed connective tissue disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
mixed connective tissue disease | SNRPB* | Snrpb | Alliance of Genome Resources | ||||
mixed connective tissue disease | SNRPC* | Snrpc | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 1 | DYSF* | Dysf | Alliance of Genome Resources | ||||
Miyoshi muscular dystrophy 3 | ANO5* | Ano5 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 1 | COMP* | Comp | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 2 | COL9A2* | Col9a2 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 3 | COL9A3* | Col9a3 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 4 | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 6 | COL9A1* | Col9a1 | Alliance of Genome Resources | ||||
multiple epiphyseal dysplasia 7 | CANT1* | Cant1 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 1 | NOG* | Nog | Alliance of Genome Resources | ||||
multiple synostoses syndrome 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 3 | FGF9* | Fgf9 | Alliance of Genome Resources | ||||
multiple synostoses syndrome 4 | GDF6* | Gdf6 | Alliance of Genome Resources | ||||
muscular disease | ITGA7* | Itga7 | Alliance of Genome Resources | ||||
muscular disease | CLU* | Clu | Alliance of Genome Resources | ||||
muscular disease | CPT2* | Cpt2 | Alliance of Genome Resources | ||||
muscular disease | LPL* | Lpl | Alliance of Genome Resources | ||||
muscular disease | TUBG1* | Tubg1 | Alliance of Genome Resources | ||||
muscular disease | HMGCR* | Hmgcr | Alliance of Genome Resources | ||||
muscular dystrophy | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
muscular dystrophy | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
muscular dystrophy | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
muscular dystrophy | MYOT* | Myot | Alliance of Genome Resources | ||||
muscular dystrophy | LAMA2* | Lama2 | Alliance of Genome Resources | ||||
muscular dystrophy | FKTN* | Fktn | Alliance of Genome Resources | ||||
muscular dystrophy | DYSF* | Dysf | Alliance of Genome Resources | ||||
muscular dystrophy | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
muscular dystrophy | CHKB* | Chkb | Alliance of Genome Resources | ||||
muscular dystrophy | CAV3* | Cav3 | Alliance of Genome Resources | ||||
muscular dystrophy | CAPN3* | Capn3 | Alliance of Genome Resources | ||||
muscular dystrophy | TRIM32* | Trim32 | Alliance of Genome Resources | ||||
muscular dystrophy | SYNE1* | Syne1 | Alliance of Genome Resources | ||||
muscular dystrophy | SGCD* | Sgcd | Alliance of Genome Resources | ||||
muscular dystrophy | SGCB* | Sgcb | Alliance of Genome Resources | ||||
muscular dystrophy | SGCA* | Sgca | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B14 | GMPPB* | Gmppb | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B15 | DPM3* | Dpm3 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B2 | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B3 | POMGNT1* | Pomgnt1 | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type B4 | FKTN* | Fktn | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C12 | POMK* | Pomk | Alliance of Genome Resources | ||||
muscular dystrophy-dystroglycanopathy type C8 | POMGNT2* | Pomgnt2 | Alliance of Genome Resources | ||||
myofibrillar myopathy 10 | SVIL* | Svil | Alliance of Genome Resources | ||||
myofibrillar myopathy 11 | UNC45B* | Unc45b | Alliance of Genome Resources | ||||
myofibrillar myopathy 3 | MYOT* | Myot | 1 "NOT" model | Alliance of Genome Resources | |||
myofibrillar myopathy 4 | LDB3* | Ldb3 | Alliance of Genome Resources | ||||
myofibrillar myopathy 6 | BAG3* | Bag3 | Alliance of Genome Resources | ||||
myofibrillar myopathy 7 | KY* | Ky | Alliance of Genome Resources | ||||
myofibrillar myopathy 8 | PYROXD1* | Pyroxd1 | Alliance of Genome Resources | ||||
myofibrillar myopathy 9 | TTN* | Ttn | Alliance of Genome Resources | ||||
myoglobinuria | PGAM2* | Pgam2 | Alliance of Genome Resources | ||||
myopathy, lactic acidosis, and sideroblastic anemia 1 | PUS1* | Pus1 | Alliance of Genome Resources | ||||
myopathy, lactic acidosis, and sideroblastic anemia 2 | YARS2* | Yars2 | Alliance of Genome Resources | ||||
myopathy with extrapyramidal signs | MICU1* | Micu1 | Alliance of Genome Resources | ||||
myositis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
myositis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
myositis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
myositis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
myotonic dystrophy type 2 | CNBP* | Cnbp | Alliance of Genome Resources | ||||
myxoid liposarcoma | DDIT3* | Ddit3 | Alliance of Genome Resources | ||||
Nager acrofacial dysostosis | SF3B4* | Sf3b4 | Alliance of Genome Resources | ||||
Native American myopathy | STAC3* | Stac3 | Alliance of Genome Resources | ||||
nemaline myopathy | ANKRD1* | Ankrd1 | Alliance of Genome Resources | ||||
nemaline myopathy 1 | TPM3* | Tpm3 | Alliance of Genome Resources | ||||
nemaline myopathy 4 | TPM2* | Tpm2 | Alliance of Genome Resources | ||||
nemaline myopathy 5B | TNNT1* | Tnnt1 | Alliance of Genome Resources | ||||
nemaline myopathy 5C | TNNT1* | Tnnt1 | Alliance of Genome Resources | ||||
nemaline myopathy 7 | CFL2* | Cfl2 | Alliance of Genome Resources | ||||
nemaline myopathy 9 | KLHL41* | Klhl41 | Alliance of Genome Resources | ||||
neurogenic scapuloperoneal syndrome Kaeser type | DES* | Des | Alliance of Genome Resources | ||||
neuromuscular disease | GPI* | Gpi1 | Alliance of Genome Resources | ||||
oculopharyngeal muscular dystrophy | PABPN1* | Pabpn1 | 1 model | Alliance of Genome Resources | |||
oculopharyngodistal myopathy 1 | LRP12* | Lrp12 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 2 | GIPC1* | Gipc1 | Alliance of Genome Resources | ||||
oculopharyngodistal myopathy 3 | NOTCH2NLC* | ||||||
oculopharyngodistal myopathy 4 | RILPL1* | Rilpl1 | Alliance of Genome Resources | ||||
omodysplasia 1 | GPC6* | Gpc6 | Alliance of Genome Resources | ||||
omodysplasia 2 | FZD2* | Fzd2 | Alliance of Genome Resources | ||||
ossification of the posterior longitudinal ligament of spine | BMP4* | Bmp4 | Alliance of Genome Resources | ||||
osteoarthritis | GHR* | Ghr | Alliance of Genome Resources | ||||
osteoarthritis | ADAM12* | Adam12 | Alliance of Genome Resources | ||||
osteoarthritis | ADAMTS5* | Adamts5 | Alliance of Genome Resources | ||||
osteoarthritis | ADAMTS14* | Adamts14 | Alliance of Genome Resources | ||||
osteoarthritis | ASPN* | Aspn | Alliance of Genome Resources | ||||
osteoarthritis | BAG6* | Bag6 | Alliance of Genome Resources | ||||
osteoarthritis | BGLAP* | Bglap, Bglap2, Bglap3 | Alliance of Genome Resources | ||||
osteoarthritis | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
osteoarthritis | CD36* | Cd36 | Alliance of Genome Resources | ||||
osteoarthritis | CILP* | Cilp | Alliance of Genome Resources | ||||
osteoarthritis | CLEC3B* | Clec3b | Alliance of Genome Resources | ||||
osteoarthritis | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
osteoarthritis | DDR2* | Ddr2 | Alliance of Genome Resources | ||||
osteoarthritis | ESR1* | Esr1 | Alliance of Genome Resources | ||||
osteoarthritis | ESR2* | Esr2 | Alliance of Genome Resources | ||||
osteoarthritis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
osteoarthritis | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
osteoarthritis | FRZB* | Frzb | Alliance of Genome Resources | ||||
osteoarthritis | HFE* | Hfe | Alliance of Genome Resources | ||||
osteoarthritis | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
osteoarthritis | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
osteoarthritis | NCOR2* | Ncor2 | Alliance of Genome Resources | ||||
osteoarthritis | POMC* | Pomc | Alliance of Genome Resources | ||||
osteoarthritis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
osteoarthritis | TENT5A* | Tent5a | Alliance of Genome Resources | ||||
osteoarthritis | TNFRSF11B* | Tnfrsf11b | Alliance of Genome Resources | ||||
osteochondrodysplasia | BMPR1B* | Bmpr1b | Alliance of Genome Resources | ||||
osteochondrodysplasia | CHST3* | Chst3 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL9A3* | Col9a3 | Alliance of Genome Resources | ||||
osteochondrodysplasia | TRPS1* | Trps1 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
osteochondrodysplasia | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COMP* | Comp | Alliance of Genome Resources | ||||
osteochondrodysplasia | DYM* | Dym | Alliance of Genome Resources | ||||
osteochondrodysplasia | FLNA* | Flna | Alliance of Genome Resources | ||||
osteochondrodysplasia | FLNB* | Flnb | Alliance of Genome Resources | ||||
osteochondrodysplasia | HSPG2* | Hspg2 | Alliance of Genome Resources | ||||
osteochondrodysplasia | LIFR* | Lifr | Alliance of Genome Resources | ||||
osteochondrodysplasia | MATN3* | Matn3 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL9A1* | Col9a1 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL10A1* | Col10a1 | Alliance of Genome Resources | ||||
osteochondrodysplasia | PTH1R* | Pth1r | Alliance of Genome Resources | ||||
osteochondrodysplasia | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
osteochondrodysplasia | COL9A2* | Col9a2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta | CCDC134* | Ccdc134 | Alliance of Genome Resources | ||||
osteogenesis imperfecta | PHLDB1* | Phldb1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 11 | FKBP10* | Fkbp10 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 12 | SP7* | Sp7 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 13 | BMP1* | Bmp1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 14 | TMEM38B* | Tmem38b | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 15 | WNT1* | Wnt1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 16 | CREB3L1* | Creb3l1 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 17 | SPARC* | Sparc | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 18 | TENT5A* | Tent5a | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 19 | MBTPS2* | Mbtps2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 2 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 20 | MESD* | Mesd | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 21 | KDELR2* | Kdelr2 | Alliance of Genome Resources | ||||
osteogenesis imperfecta type 4 | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteoglophonic dysplasia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
osteomyelitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
osteonecrosis | F2* | F2 | Alliance of Genome Resources | ||||
osteonecrosis | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
osteonecrosis | F5* | F5 | Alliance of Genome Resources | ||||
osteonecrosis | ABCB1* | Abcb1a, Abcb1b | Alliance of Genome Resources | ||||
osteonecrosis | TFPI* | Tfpi | Alliance of Genome Resources | ||||
osteonecrosis | PLAT* | Plat | Alliance of Genome Resources | ||||
osteonecrosis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
osteonecrosis | NOS3* | Nos3 | Alliance of Genome Resources | ||||
osteonecrosis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
osteonecrosis | IL23R* | Il23r | Alliance of Genome Resources | ||||
osteonecrosis | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
osteonecrosis | CAT* | Cat | Alliance of Genome Resources | ||||
osteonecrosis | ANXA2*, ANXA2P2 | Anxa2 | Alliance of Genome Resources | ||||
osteopetrosis | SLC4A2* | Slc4a2 | Alliance of Genome Resources | ||||
osteopetrosis | PLEKHM1* | Plekhm1 | Alliance of Genome Resources | ||||
osteopetrosis | CA2* | Car2 | Alliance of Genome Resources | ||||
osteoporosis | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
osteoporosis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
osteoporosis | SOD2* | Sod2 | Alliance of Genome Resources | ||||
osteoporosis | PDLIM4* | Pdlim4 | Alliance of Genome Resources | ||||
osteoporosis | NRIP1* | Nrip1 | Alliance of Genome Resources | ||||
osteoporosis | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
osteoporosis | LEPR* | Lepr | Alliance of Genome Resources | ||||
osteoporosis | LEP* | Lep | Alliance of Genome Resources | ||||
osteoporosis | IL32* | ||||||
osteoporosis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
osteoporosis | IL1A* | Il1a | Alliance of Genome Resources | ||||
osteoporosis | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
osteoporosis | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
osteoporosis | ESR2* | Esr2 | Alliance of Genome Resources | ||||
osteoporosis | ESR1* | Esr1 | Alliance of Genome Resources | ||||
osteoporosis | DBP* | Dbp | Alliance of Genome Resources | ||||
osteoporosis | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
osteoporosis | CYP17A1* | Cyp17a1 | Alliance of Genome Resources | ||||
osteoporosis | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
osteoporosis | COL1A2* | Col1a2 | Alliance of Genome Resources | ||||
osteoporosis | COL1A1* | Col1a1 | Alliance of Genome Resources | ||||
osteoporosis | CALCR* | Calcr | Alliance of Genome Resources | ||||
osteoporosis | CALCA*, CALCB | Calca, Calcb | Alliance of Genome Resources | ||||
osteoporosis | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
osteoporosis | BGLAP* | Bglap, Bglap2, Bglap3 | Alliance of Genome Resources | ||||
osteosarcoma | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
osteosarcoma | RB1* | Rb1 | 6 models | Alliance of Genome Resources | |||
osteosarcoma | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
osteosarcoma | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
osteosarcoma | CDC5L* | Cdc5l, Cdc5lrt1, Cdc5lrt4, Cdc5lrt5, Cdc5lrt6, Cdc5lrt7, Cdc5lrt8, Cdc5lrt9, Cdc5lrt10 | Alliance of Genome Resources | ||||
osteosarcoma | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
osteosarcoma | EFEMP2* | Efemp2 | Alliance of Genome Resources | ||||
osteosarcoma | E2F1* | E2f1 | Alliance of Genome Resources | ||||
osteosarcoma | PTH* | Pth | Alliance of Genome Resources | ||||
osteosarcoma | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
osteosarcoma | DDR1* | Ddr1 | Alliance of Genome Resources | ||||
osteosarcoma | MIR624* | ||||||
osteosarcoma | MIR494* | Mir494 | Alliance of Genome Resources | ||||
osteosarcoma | GSTM3* | Gstm5 | Alliance of Genome Resources | ||||
osteosarcoma | EZH2* | Ezh2 | Alliance of Genome Resources | ||||
osteosclerotic metaphyseal dysplasia | LRRK1* | Lrrk1 | Alliance of Genome Resources | ||||
otopalatodigital syndrome spectrum disorder | FLNA* | Flna | Alliance of Genome Resources | ||||
otopalatodigital syndrome type 1 | FLNA* | Flna | Alliance of Genome Resources | ||||
otopalatodigital syndrome type 2 | FLNA* | Flna | Alliance of Genome Resources | ||||
otospondylomegaepiphyseal dysplasia, autosomal dominant | COL11A2* | Col11a2 | Alliance of Genome Resources | ||||
Paget's disease of bone | TNFRSF11B* | Tnfrsf11b | Alliance of Genome Resources | ||||
Paget's disease of bone | OPTN* | Optn | Alliance of Genome Resources | ||||
Paget's disease of bone | VCP* | Vcp | Alliance of Genome Resources | ||||
Paget's disease of bone 2 | TNFRSF11A* | Tnfrsf11a | Alliance of Genome Resources | ||||
Paget's disease of bone 3 | SQSTM1* | Sqstm1 | Alliance of Genome Resources | ||||
Paget's disease of bone 5 | TNFRSF11B* | Tnfrsf11b | Alliance of Genome Resources | ||||
Paget's disease of bone 6 | ZNF687* | Zfp687 | Alliance of Genome Resources | ||||
paramyotonia congenita of Von Eulenburg | SCN4A* | Scn4a | Alliance of Genome Resources | ||||
parastremmatic dwarfism | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
partial lipodystrophy | LMNB2* | Lmnb2 | Alliance of Genome Resources | ||||
pemphigus | CD36* | Cd36 | Alliance of Genome Resources | ||||
pemphigus | IL2* | Il2 | Alliance of Genome Resources | ||||
pemphigus | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
pemphigus | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
pemphigus | CAST* | Cast | Alliance of Genome Resources | ||||
pemphigus | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
pemphigus | CD40* | Cd40 | Alliance of Genome Resources | ||||
pemphigus vulgaris | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
pneumoconiosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
polymyalgia rheumatica | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
polymyalgia rheumatica | HFE* | Hfe | Alliance of Genome Resources | ||||
polymyositis | ELN* | Eln | Alliance of Genome Resources | ||||
polymyositis | STAT4* | Stat4 | Alliance of Genome Resources | ||||
polymyositis | PMS1* | Pms1 | Alliance of Genome Resources | ||||
proximal symphalangism | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 1 | NOG* | Nog | Alliance of Genome Resources | ||||
proximal symphalangism 2 | GDF5* | Gdf5 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | GPX1* | Gpx1 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | SOD2* | Sod2 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | XYLT2* | Xylt2 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | XYLT1* | Xylt1 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | ELN* | Eln | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | MMP2* | Mmp2 | Alliance of Genome Resources | ||||
pseudoxanthoma elasticum | CAT* | Cat | Alliance of Genome Resources | ||||
psoriasis | VDR* | Vdr | Alliance of Genome Resources | ||||
psoriasis | TNF* | Tnf | Alliance of Genome Resources | ||||
psoriasis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
psoriasis | TAP1* | Tap1 | Alliance of Genome Resources | ||||
psoriasis | STAT4* | Stat4 | Alliance of Genome Resources | ||||
psoriasis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
psoriasis | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
psoriasis | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
psoriasis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
psoriasis | LTA* | Lta | Alliance of Genome Resources | ||||
psoriasis | IL23R* | Il23r | Alliance of Genome Resources | ||||
psoriasis | IL20* | Il20 | Alliance of Genome Resources | ||||
psoriasis | IL17A* | Il17a | Alliance of Genome Resources | ||||
psoriasis | IL13* | Il13 | Alliance of Genome Resources | ||||
psoriasis | IL10* | Il10 | Alliance of Genome Resources | ||||
psoriasis | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
psoriasis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
psoriasis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
psoriasis | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
psoriasis | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
psoriasis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
psoriasis | COMT* | Comt | Alliance of Genome Resources | ||||
psoriasis | CFB* | Cfb | Alliance of Genome Resources | ||||
psoriasis | CD40* | Cd40 | Alliance of Genome Resources | ||||
psoriasis | CAST* | Cast | Alliance of Genome Resources | ||||
psoriasis | CADM2* | Cadm2 | Alliance of Genome Resources | ||||
psoriasis | C2* | C2 | Alliance of Genome Resources | ||||
psoriasis | BANK1* | Bank1 | Alliance of Genome Resources | ||||
psoriasis | APOE* | Apoe | Alliance of Genome Resources | ||||
psoriasis | ALB* | Alb | Alliance of Genome Resources | ||||
psoriasis | AGER* | Ager | Alliance of Genome Resources | ||||
psoriasis | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
psoriasis 1 | HLA-C*, HLA-A, HLA-B, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
psoriasis 13 | TRAF3IP2* | Traf3ip2 | Alliance of Genome Resources | ||||
psoriasis 15 | AP1S3* | Ap1s3 | Alliance of Genome Resources | ||||
psoriasis 7 | IL23R* | Il23r | Alliance of Genome Resources | ||||
psoriatic arthritis | CCR2* | Ccr2 | Alliance of Genome Resources | ||||
psoriatic arthritis | STAT4* | Stat4 | Alliance of Genome Resources | ||||
psoriatic arthritis | TNF* | Tnf | Alliance of Genome Resources | ||||
psoriatic arthritis | IL17A* | Il17a | Alliance of Genome Resources | ||||
psoriatic arthritis | PECAM1* | Pecam1 | Alliance of Genome Resources | ||||
psoriatic arthritis | IRAK1* | Irak1 | Alliance of Genome Resources | ||||
psoriatic arthritis | STAT3* | Stat3 | Alliance of Genome Resources | ||||
psoriatic arthritis | IL13* | Il13 | Alliance of Genome Resources | ||||
psoriatic arthritis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
psoriatic arthritis | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
psoriatic arthritis | LTA* | Lta | Alliance of Genome Resources | ||||
pulmonary fibrosis | PLAU* | Plau | Alliance of Genome Resources | ||||
pulmonary fibrosis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
pulmonary fibrosis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
pulmonary fibrosis | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
pulmonary fibrosis | IL1A* | Il1a | Alliance of Genome Resources | ||||
pulmonary fibrosis | SFTPA1*, SFTPA2 | Sftpa1 | Alliance of Genome Resources | ||||
pulmonary fibrosis | SFTPB* | Sftpb | Alliance of Genome Resources | ||||
pulmonary fibrosis | CXCL8* | ||||||
pulmonary fibrosis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
pulmonary fibrosis | CHRM3* | Chrm3 | Alliance of Genome Resources | ||||
pulmonary fibrosis | BDKRB1* | Bdkrb1 | Alliance of Genome Resources | ||||
pulmonary fibrosis | AP3B1* | Ap3b1 | Alliance of Genome Resources | ||||
pulmonary fibrosis | SFTPC* | Sftpc | Alliance of Genome Resources | ||||
pulmonary fibrosis | TFPI* | Tfpi | Alliance of Genome Resources | ||||
pulmonary fibrosis | TNF* | Tnf | Alliance of Genome Resources | ||||
pulmonary fibrosis | TGFB1* | Tgfb1 | Alliance of Genome Resources | ||||
pustular psoriasis 14 | IL36RN* | Il36rn | Alliance of Genome Resources | ||||
pycnodysostosis | CTSK* | Ctsk | Alliance of Genome Resources | ||||
reactive arthritis | TAP1* | Tap1 | Alliance of Genome Resources | ||||
reactive arthritis | SOD2* | Sod2 | Alliance of Genome Resources | ||||
reactive arthritis | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
reactive arthritis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
reactive arthritis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
reducing body myopathy 1A | FHL1* | Fhl1 | Alliance of Genome Resources | ||||
reducing body myopathy 1B | FHL1* | Fhl1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | NFKBIL1* | Nfkbil1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | NCF4* | Ncf4 | Alliance of Genome Resources | ||||
rheumatoid arthritis | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
rheumatoid arthritis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | HFE* | Hfe | Alliance of Genome Resources | ||||
rheumatoid arthritis | IFNG* | Ifng | Alliance of Genome Resources | ||||
rheumatoid arthritis | NCF2* | Ncf2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
rheumatoid arthritis | ND1* | mt-Nd1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | IGF2* | Igf2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
rheumatoid arthritis | MBD4* | Mbd4 | Alliance of Genome Resources | ||||
rheumatoid arthritis | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
rheumatoid arthritis | ITPA* | Itpa | Alliance of Genome Resources | ||||
rheumatoid arthritis | ELN* | Eln | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
rheumatoid arthritis | ESR2* | Esr2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | CAST* | Cast | Alliance of Genome Resources | ||||
rheumatoid arthritis | EDN1* | Edn1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | DNMT3B* | Dnmt3b | Alliance of Genome Resources | ||||
rheumatoid arthritis | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
rheumatoid arthritis | CIITA* | Ciita | Alliance of Genome Resources | ||||
rheumatoid arthritis | CD244* | Cd244a | Alliance of Genome Resources | ||||
rheumatoid arthritis | CD40* | Cd40 | Alliance of Genome Resources | ||||
rheumatoid arthritis | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
rheumatoid arthritis | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
rheumatoid arthritis | CCR1* | Ccr1, Ccr1l1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
rheumatoid arthritis | BGLAP* | Bglap, Bglap2, Bglap3 | Alliance of Genome Resources | ||||
rheumatoid arthritis | BTNL2* | Btnl2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | C4B*, C4A, C4B_2 | C4a, C4b | Alliance of Genome Resources | ||||
rheumatoid arthritis | VIM* | Vim | Alliance of Genome Resources | ||||
rheumatoid arthritis | VDR* | Vdr | Alliance of Genome Resources | ||||
rheumatoid arthritis | TYMS* | Tyms | Alliance of Genome Resources | ||||
rheumatoid arthritis | TNFRSF1A* | Tnfrsf1a | Alliance of Genome Resources | ||||
rheumatoid arthritis | THBD* | Thbd | Alliance of Genome Resources | ||||
rheumatoid arthritis | TAP2* | Tap2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | STAT3* | Stat3 | Alliance of Genome Resources | ||||
rheumatoid arthritis | SPP1* | Spp1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | SLC22A4* | Slc22a4 | Alliance of Genome Resources | ||||
rheumatoid arthritis | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
rheumatoid arthritis | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
rheumatoid arthritis | PLAUR* | Plaur | Alliance of Genome Resources | ||||
rheumatoid arthritis | OPRM1* | Oprm1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | NPSR1* | Npsr1 | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL1A* | Il1a | Alliance of Genome Resources | ||||
rheumatoid arthritis | IRF5* | Irf5 | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL23R* | Il23r | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL17A* | Il17a | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL10* | Il10 | Alliance of Genome Resources | ||||
rheumatoid arthritis | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
rheumatoid arthritis | FAS* | Fas | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL4R* | Il4ra | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL3* | Il3 | Alliance of Genome Resources | ||||
rheumatoid arthritis | IL2* | Il2 | Alliance of Genome Resources | ||||
Saethre-Chotzen syndrome | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
Saul-Wilson syndrome | COG4* | Cog4 | Alliance of Genome Resources | ||||
scleroderma | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
sclerosteosis | SOST* | Sost | Alliance of Genome Resources | ||||
scoliosis | TPH1* | Tph1 | Alliance of Genome Resources | ||||
scoliosis | FBN2* | Fbn2 | Alliance of Genome Resources | ||||
scoliosis | FBN1* | Fbn1 | Alliance of Genome Resources | ||||
scoliosis | ELP1* | Elp1 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 10 with or without polydactyly | IFT172* | Ift172 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 11 with or without polydactyly | DYNC2I2* | Dync2i2 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 13 with or without polydactyly | CEP120* | Cep120 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 14 with polydactyly | KIAA0586* | 2700049A03Rik | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 18 with polydactyly | IFT43* | Ift43 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 19 with or without polydactyly | IFT81* | Ift81 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 6 with or without polydactyly | NEK1* | Nek1 | Alliance of Genome Resources | ||||
short-rib thoracic dysplasia 8 with or without polydactyly | DYNC2I1* | Dync2i1 | Alliance of Genome Resources | ||||
SHOX-related short stature | SHOX* | ||||||
sick sinus syndrome | MYH6* | Myh6 | Alliance of Genome Resources | ||||
sick sinus syndrome | AGT* | Agt | Alliance of Genome Resources | ||||
sick sinus syndrome | ANK2* | Ank2 | Alliance of Genome Resources | ||||
sick sinus syndrome | HCN4* | Hcn4 | 1 model | Alliance of Genome Resources | |||
silicosis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
silicosis | C3* | C3 | Alliance of Genome Resources | ||||
silicosis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
silicosis | TNF* | Tnf | Alliance of Genome Resources | ||||
Smith-McCort dysplasia 1 | DYM* | Dym | Alliance of Genome Resources | ||||
spinal disease | FLNB* | Flnb | Alliance of Genome Resources | ||||
split hand-foot malformation 1 with sensorineural hearing loss | DLX5* | Dlx5 | Alliance of Genome Resources | ||||
split hand-foot malformation 4 | TP63* | Trp63 | Alliance of Genome Resources | ||||
split hand-foot malformation 6 | WNT10B* | Wnt10b | Alliance of Genome Resources | ||||
spondyloarthropathy | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
spondyloarthropathy | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 1 | DLL3* | Dll3 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 2 | MESP2* | Mesp2 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 3 | LFNG* | Lfng | Alliance of Genome Resources | ||||
spondylocostal dysostosis 4 | HES7* | Hes7 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 5 | TBX6* | Tbx6 | Alliance of Genome Resources | ||||
spondylocostal dysostosis 6 | RIPPLY2* | Ripply2 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Genevieve-type | NANS* | Nans | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Missouri type | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Sponastrime type | TONSL* | Tonsl | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia, Strudwick type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 1 | B3GALT6* | B3galt6 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 2 | KIF22* | Kif22 | Alliance of Genome Resources | ||||
spondyloepimetaphyseal dysplasia with joint laxity type 3 | EXOC6B* | Exoc6b | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Kimberley type | ACAN* | Acan | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Kondo-Fu type | MBTPS1* | Mbtps1 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Maroteaux type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Nishimura type | MIR140* | Mir140 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia Stanescu type | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondyloepiphyseal dysplasia with congenital joint dislocations | CHST3* | Chst3 | Alliance of Genome Resources | ||||
spondylolysis | SLC26A2* | Slc26a2 | Alliance of Genome Resources | ||||
spondylometaepiphyseal dysplasia, short limb-hand type | DDR2* | Ddr2 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia | PRKG2* | Prkg2 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia | ACP5* | Acp5 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia corner fracture type | FN1* | Fn1 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Kozlowski type | TRPV4* | Trpv4 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Megarbane-Dagher-Melike type | PAM16* | Pam16, Pam16l | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia Sedaghatian type | GPX4* | Gpx4 | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia with cone-rod dystrophy | PCYT1A* | Pcyt1a | Alliance of Genome Resources | ||||
spondylometaphyseal dysplasia with corneal dystrophy | PLCB3* | Plcb3 | Alliance of Genome Resources | ||||
spondyloperipheral dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
spondylosis | KL* | Kl | Alliance of Genome Resources | ||||
syndactyly | GLI3* | Gli3 | Alliance of Genome Resources | ||||
syndactyly | IRF6* | Irf6 | Alliance of Genome Resources | ||||
syndactyly type 1 | IHH* | Ihh | Alliance of Genome Resources | ||||
syndactyly type 3 | GJA1*, GJA6P | Gja1, Gja6 | Alliance of Genome Resources | ||||
syndactyly type 4 | SHH* | Shh | Alliance of Genome Resources | ||||
syndactyly type 4 | LMBR1* | Lmbr1 | Alliance of Genome Resources | ||||
syndactyly type 5 | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
syndactyly type 8 | FGF16* | Fgf16 | Alliance of Genome Resources | ||||
synovial sarcoma | SSX2*, SSX1, SSX2B, SSX3, SSX4, SSX4B, SSX5, SSX6P, SSX7, SSX8P, SSX9P | Ssxa1, Ssxb1, Ssxb2, Ssxb3, Ssxb5, Ssxb6, Ssxb8, Ssxb9, Ssxb10, Ssxb13, Ssxb14, Ssxb15, Ssxb16 | Alliance of Genome Resources | ||||
synovial sarcoma | SS18* | Ss18 | Alliance of Genome Resources | ||||
synovitis | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | VIM* | Vim | Alliance of Genome Resources | ||||
systemic lupus erythematosus | TREX1* | Trex1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | TNF* | Tnf | Alliance of Genome Resources | ||||
systemic lupus erythematosus | TLR9* | Tlr9 | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | TLR5* | Tlr5 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | TAP2* | Tap2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | STAT4* | Stat4 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SOD2* | Sod2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SNRPD3* | Snrpd3 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SNRPD2* | Snrpd2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SNRPD1* | Snrpd1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SNRPC* | Snrpc | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SNRNP70* | Snrnp70 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | RPL14* | Rpl14 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | RPL12* | Rpl12 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | PTPN22* | Ptpn22 | 1 model | Alliance of Genome Resources | |||
systemic lupus erythematosus | NOD2* | Nod2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | KLKB1* | Klkb1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IRF8* | Irf8 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IRF5* | Irf5 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL21R* | Il21r | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL21* | Il21 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL10* | Il10 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL2* | Il2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
systemic lupus erythematosus | IL1B* | Il1b | Alliance of Genome Resources | ||||
systemic lupus erythematosus | HSPA1L* | Hspa1l | Alliance of Genome Resources | ||||
systemic lupus erythematosus | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
systemic lupus erythematosus | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | FCGR3A*, FCGR3B | Fcgr4 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | F2* | F2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | ESR2* | Esr2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | EPOR* | Epor | Alliance of Genome Resources | ||||
systemic lupus erythematosus | ELN* | Eln | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CRP* | Crp | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CR2* | Cr2 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CIITA* | Ciita | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CHAF1A* | Chaf1a | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CFH* | Cfh, Cfhr4 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CD40* | Cd40 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | CAST* | Cast | Alliance of Genome Resources | ||||
systemic lupus erythematosus | C3* | C3 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | BLK* | Blk | Alliance of Genome Resources | ||||
systemic lupus erythematosus | BANK1* | Bank1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | ATP6* | Atp6-ps, mt-Atp6 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | APOA1* | Apoa1 | Alliance of Genome Resources | ||||
systemic lupus erythematosus | AGER* | Ager | Alliance of Genome Resources | ||||
systemic scleroderma | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
systemic scleroderma | ELN* | Eln | Alliance of Genome Resources | ||||
systemic scleroderma | ESR1* | Esr1 | Alliance of Genome Resources | ||||
systemic scleroderma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
systemic scleroderma | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
systemic scleroderma | HGF* | Hgf | Alliance of Genome Resources | ||||
systemic scleroderma | HNRNPL* | Hnrnpl | Alliance of Genome Resources | ||||
systemic scleroderma | IFNG* | Ifng | Alliance of Genome Resources | ||||
systemic scleroderma | IL1B* | Il1b | Alliance of Genome Resources | ||||
systemic scleroderma | IL1R1* | Il1r1 | Alliance of Genome Resources | ||||
systemic scleroderma | IL23R* | Il23r | Alliance of Genome Resources | ||||
systemic scleroderma | LTA* | Lta | Alliance of Genome Resources | ||||
systemic scleroderma | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
systemic scleroderma | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
systemic scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
systemic scleroderma | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
systemic scleroderma | MMP9* | Mmp9 | Alliance of Genome Resources | ||||
systemic scleroderma | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
systemic scleroderma | ANXA5* | Anxa5 | Alliance of Genome Resources | ||||
systemic scleroderma | BANK1* | Bank1 | Alliance of Genome Resources | ||||
systemic scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
systemic scleroderma | CD86* | Cd86 | Alliance of Genome Resources | ||||
systemic scleroderma | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
tarsal-carpal coalition syndrome | NOG* | Nog | Alliance of Genome Resources | ||||
Thomsen disease | CLCN1* | Clcn1 | Alliance of Genome Resources | ||||
Tietze's syndrome | MITF* | Mitf | Alliance of Genome Resources | ||||
Torrance type platyspondylic dysplasia | COL2A1* | Col2a1 | Alliance of Genome Resources | ||||
tubular aggregate myopathy 2 | ORAI1* | Orai1 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1A | COL6A1* | Col6a1 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1B | COL6A2* | Col6a2 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 1C | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
Ullrich congenital muscular dystrophy 2 | COL12A1* | Col12a1 | Alliance of Genome Resources | ||||
visceral leishmaniasis | LTA* | Lta | Alliance of Genome Resources | ||||
visceral leishmaniasis | CXCL8* | ||||||
visceral leishmaniasis | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
visceral leishmaniasis | IL32* | ||||||
visceral leishmaniasis | TNF* | Tnf | Alliance of Genome Resources | ||||
visceral leishmaniasis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
visceral leishmaniasis | CSF2* | Csf2 | Alliance of Genome Resources | ||||
visceral leishmaniasis | IL2RB* | Il2rb | Alliance of Genome Resources | ||||
visceral leishmaniasis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 1A | CYP27B1* | Cyp27b1 | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 1B | CYP2R1* | Cyp2r1 | Alliance of Genome Resources | ||||
vitamin D-dependent rickets type 2A | VDR* | Vdr | Alliance of Genome Resources | ||||
vitiligo | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
vitiligo | HGF* | Hgf | Alliance of Genome Resources | ||||
vitiligo | HSPA1A*, HSPA1B | Hspa1a, Hspa1b | Alliance of Genome Resources | ||||
vitiligo | CAT* | Cat | Alliance of Genome Resources | ||||
vitiligo | IFNG* | Ifng | Alliance of Genome Resources | ||||
vitiligo | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
vitiligo | NLRP1* | Nlrp1a, Nlrp1b | Alliance of Genome Resources | ||||
vitiligo | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
vitiligo | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
vitiligo | SOD2* | Sod2 | Alliance of Genome Resources | ||||
vitiligo | VDR* | Vdr | Alliance of Genome Resources | ||||
vitiligo | TYR* | Tyr | Alliance of Genome Resources | ||||
vitiligo | TLR4* | Tlr4 | Alliance of Genome Resources | ||||
vitiligo | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
vitiligo | COMT* | Comt | Alliance of Genome Resources | ||||
vitiligo | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
vitiligo | C4A*, C4B, C4B_2 | C4a, C4b | Alliance of Genome Resources | ||||
vitiligo | ESR1* | Esr1 | Alliance of Genome Resources | ||||
vitiligo | FOXD3* | Foxd3 | Alliance of Genome Resources | ||||
vitiligo | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
vitiligo | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
Vogt-Koyanagi-Harada disease | STAT4* | Stat4 | Alliance of Genome Resources | ||||
Vogt-Koyanagi-Harada disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Vogt-Koyanagi-Harada disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
Vogt-Koyanagi-Harada disease | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | POMT1* | Pomt1 | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKRP* | Fkrp | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | FKTN* | Fktn | Alliance of Genome Resources | ||||
Walker-Warburg syndrome | POMT2* | Pomt2 | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC2* | Evc2 | Alliance of Genome Resources | ||||
Weyers acrofacial dysostosis | EVC* | Evc | Alliance of Genome Resources | ||||
Worth syndrome | LRP5*, LRP5L | Lrp5 | Alliance of Genome Resources | ||||
X-linked Emery-Dreifuss muscular dystrophy 1 | EMD* | Emd | Alliance of Genome Resources | ||||
X-linked Emery-Dreifuss muscular dystrophy 6 | FHL1* | Fhl1 | Alliance of Genome Resources | ||||
X-linked myopathy with excessive autophagy | VMA21* | Vma21 | Alliance of Genome Resources | ||||
X-linked recessive hypophosphatemic rickets | CLCN5* | Clcn5 | Alliance of Genome Resources | ||||
X-linked spondyloepimetaphyseal dysplasia | BGN* | Bgn | Alliance of Genome Resources | ||||
X-linked spondyloepiphyseal dysplasia tarda | TRAPPC2*, TRAPPC2B | Trappc2, Trappc2b | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
achondroplasia | Tg(Col2a1-Fgfr3/GH)BDor | 1 model | |
achondroplasia | Tg(FGFR3-G380R)7Aya | 2 models | |
autosomal dominant hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
autosomal dominant limb-girdle muscular dystrophy type 1 | Tg(Ckm-DNAJB6_ib*F93L)#Ccwe | 1 model | |
autosomal recessive hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
bone development disease | Tg(Col11a2-Npr2*)28Keoz | 1 model | |
centronuclear myopathy | Tg(Myh7-Pln)2Egk | 1 model | |
Charcot-Marie-Tooth disease axonal type 2F | Tg(Thy1-HSPB1*S135F)#Lvdb | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C22Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)My41Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C61Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(Pmp22)247Ueli | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(tetO/CMV-Pmp22)JP18Clh | 1 model | |
Charcot-Marie-Tooth disease type 1A | Tg(PMP22)C3Fbas | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.2Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.1Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz)88.4Mfel | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)30Mes | 1 model | |
Charcot-Marie-Tooth disease type 1B | Tg(Mpz*S63X)31Mes | 2 models | |
Charcot-Marie-Tooth disease type 1C | Tg(CMV-LITAF*W116G)#Lli | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc | 1 model | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L51Ugfm | 2 models | |
Charcot-Marie-Tooth disease type 2A2A | Tg(Eno2-MFN2*R94Q)L87Ugfm | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(tetO-NEFL)173.2Jpj | 1 model | |
Charcot-Marie-Tooth disease type 2E | Tg(NEFL*E397K)#Milg | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)33Mes | 1 model | |
Charcot-Marie-Tooth disease type 3 | Tg(Mpz*S63C)32Mes | 1 model | |
Charcot-Marie-Tooth disease type 4J | Tg(ACTB-Fig4*I41T)705Mm | 1 model | |
congenital generalized lipodystrophy type 2 | Tg(aP2-SREBF1c)9884Reh | 1 model | |
congenital myasthenic syndrome 3A | Tg(Ckm-Chrnd*S262T)40Cgz | 1 model | |
congenital myasthenic syndrome 4A | Tg(Ckm-Chrne*L269F)5Cgz | 1 model | |
craniosynostosis | Tg(Msx2)1Rem | 1 model | |
craniosynostosis | Tg(Nell1)1Ting | 1 model | |
craniosynostosis | Tg(CMV-Msx2*P7H)1Rem | 1 model | |
craniosynostosis | Tg(Timp1-Msx2*P7H)1Rem | 1 model | |
dermatomyositis | Tg(Krt14-Angptl2)1Yo | 1 model | |
Duchenne muscular dystrophy | Tg(ACTA1-Ctss)1Jmol | 1 model | |
facioscapulohumeral muscular dystrophy | Tg(ACTA1-FRG1)medRotu | 1 model | |
facioscapulohumeral muscular dystrophy | Tg(ACTA1-FRG1)highRotu | 1 model | |
familial partial lipodystrophy | Tg(Fabp4-LMNA*R482Q)11ACdl | 1 model | |
familial partial lipodystrophy | Tg(Fabp4-LMNA*R482Q)17CCdl | 1 model | |
fibrodysplasia ossificans progressiva | Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis | 1 model | |
fibrodysplasia ossificans progressiva | Tg(Eno2-Bmp4)3Jake | 1 model | |
hypochondrogenesis | Tg(Col2a1*G574S)1Waho | 1 model | |
idiopathic pulmonary fibrosis | Tg(SFTPC-Tnf)2Pva | 1 model | |
idiopathic pulmonary fibrosis | Tg(H2-K-Fosl2,-EGFP)13Wag | 1 model | |
inclusion body myositis | Tg(Ckm-APPSw)A6Lfa | 1 model | |
inclusion body myositis | Tg(Ckm-APPSw)A2Lfa | 1 model | |
Kaposi's sarcoma | Tg(Acta2-RAC1*G12V)33Pjgc | 2 models | |
limb-girdle muscular dystrophy | Tg(Ckm-Sgcg)4Mcn | 1 model | |
lipodystrophy | Tg(Fabp4-SREBF1)#Dajl | 1 model | |
liposarcoma | Tg(Fabp4-Il22)#Ychn | 1 model | |
mitochondrial myopathy | Del(MTmt-Tk-mt-Nd5)1Jiha | 1 model | |
myofibrillar myopathy 1 | Tg(Myh6-Des*)641Rbns | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-Cryab*R120G)708Rbns | 1 model | |
myofibrillar myopathy 2 | Tg(Myh6-CRYAB*R120G)7302Ijb | 1 model | |
myofibrillar myopathy 3 | Tg(ACTA1-MYOT*T57I)71Mah | 1 model | |
myofibrillar myopathy 6 | Tg(Myh6-BAG3*P209L)#Mswi | 1 model | |
myopathy | Tg(Ckm-LPL)MRze | 1 model | |
myopathy | Tg(Ckm-LPL)HRze | 1 model | |
myopathy | Tg(Ckm-LPL)LRze | 1 model | |
myositis | Tg(tetO-H2-K1)#Papl | 1 model | |
myotonic dystrophy type 1 | Tg(DMPK/tetO-EGFP/DMPK)5-313Masm | 1 model | |
myotonic dystrophy type 1 | Tg(DM15)26Bew | 1 model | |
myotonic dystrophy type 1 | Tg(Ckm-CUGBP1)1039Coop | 1 model | |
myotonic dystrophy type 1 | Tg(CAG-DMPK*)1323Coop | 2 models | |
myotonic dystrophy type 1 | Tg(HSA*LR)41Cath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)20bCath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)21Cath | 1 model | |
myotonic dystrophy type 1 | Tg(DMWD,DMPK*,SIX5)328Ggo | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)20aCath | 1 model | |
myotonic dystrophy type 1 | Tg(tetO-CUGBP1)3413Coop | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)32bCath | 1 model | |
myotonic dystrophy type 1 | Tg(HSA*LR)32aCath | 1 model | |
myotonic dystrophy type 1 | Tg(DMWD,DMPK*,SIX5)1177Ggo | 1 model | |
nemaline myopathy 1 | Tg(ACTA1-TPM3*M9R)4Hrd | 1 model | |
nemaline myopathy 3 | Tg(ACTA1*D286G/EGFP)#Kjno | 1 model | |
nemaline myopathy 3 | Tg(ACTA1*D286G)#Kjno | 2 models | |
oculopharyngeal muscular dystrophy | Tg(ACTA1-PABPN1*A17)1Drub | 1 model | |
osteoarthritis | Tg(MT2A-TGFBR2)4Rser | 1 model | |
osteogenesis imperfecta type 1 | Tg(COL1A1)73Prc | 1 model | |
osteogenesis imperfecta type 5 | Tg(Col1a1-Ifitm5*)1Brle | 1 model | |
osteoporosis | Tg(TNFSF11)5519Edou | 1 model | |
osteoporosis | Tg(CD4-CIITA)357Ccum | 1 model | |
osteoporosis | Tg(APCS-Tnfsf11*)#aKhs | 1 model | |
osteosarcoma | Tg(tetO-RNAi:Trp53)ASlowe | 2 models | |
osteosarcoma | Tg(Bglap2-TAg)1Rkho | 2 models | |
pseudoachondroplasia | Tg(Col2a1-rtTA,tetO-COMP*)2Jath | 1 model | |
psoriasis | Tg(tetO-Tek)1Dmt | 2 models | |
psoriasis | Tg(tetO-S100a7a)#Yus | 1 model | |
psoriasis | Tg(KRT14-Vegfa)3Dtm | 1 model | |
psoriasis | Tg(Krt14-Rac1*G12V)#Mrnk | 2 models | |
psoriasis | Tg(KRT5-TGFB1)F2020Xjw | 1 model | |
psoriasis | Tg(KRT5-Stat3*A661C*N663C)1Jdg | 1 model | |
psoriasis | Tg(ITGB1)0870Fmw | 7 models | |
psoriasis | Tg(ITGB1)0869Fmw | 7 models | |
psoriasis | Tg(ITGB1)0840Fmw | 7 models | |
psoriasis | Tg(CYP1A1-PPARD)#Jfoe | 1 model | |
psoriasis | Tg(CAG-Lyn*)#Paau | 1 model | |
pulmonary fibrosis | Tg(tetO-TGFA)22.1Kor | 1 model | |
rheumatoid arthritis | Tg(TNF)3647Gkl | 1 model | |
rheumatoid arthritis | Tg(TNF)197Gkl | 1 model | |
rheumatoid arthritis | Tg(TcraR28,TcrbR28)KRNDim | 2 models | |
rheumatoid arthritis | Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz | 1 model | |
rheumatoid arthritis | Tg(FCGR2A)11Mkz | 1 model | |
rheumatoid arthritis | Tg(CAG-SYVN1)1Tn | 1 model | |
rippling muscle disease 2 | Tg(Ckmm-Cav3)1Ysu | 1 model | |
SOST-related sclerosing bone dysplasia | Rr20 | 1 model | |
SOST-related sclerosing bone dysplasia | Tg(RP11-209M4)AGglo | 2 models | |
split hand-foot malformation 1 | Del(6Dlx6-Dlx5)1Tlu | 1 model | |
spondyloepiphyseal dysplasia congenita | Tg(Col2a1*R789C)#Waho | 1 model | |
systemic lupus erythematosus | Igh-J | 4 models | |
systemic lupus erythematosus | Tg(ACTB-TNFRSF6B)754Jwu | 1 model | |
systemic lupus erythematosus | Tg(Igh-V-CD40lg)#Tsub | 1 model | |
systemic lupus erythematosus | Tg(Tlr7)1Boll | 1 model | |
systemic lupus erythematosus | Yaa | 5 models | |
systemic scleroderma | Tg(H2-K-Fosl2,-EGFP)13Wag | 1 model | |
X-linked dominant hypophosphatemic rickets | Tg(APOE-FGF23*R176Q)#Ack | 1 model | |
X-linked dominant hypophosphatemic rickets | Tg(Col1a1-FGF2*,-Sapphire)203Mmh | 1 model |